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Diabetes mellitus is a chronic disease characterized by hyperglycaemia. It 
occurs when the b cells of the pancreas produce either low levels of insulin 
or no insulin at all. The chronic hyperglycaemic condition of diabetes is 
associated with the dysfunction, long-term damage and failure of organs 
such as the heart and blood vessels. Diabetes is closely linked to the 
prevalence of cardiovascular diseases, which is one of the highest causes 
of death worldwide. In particular, the hyperglycaemic and chronic 
inflammatory state of diabetes has been linked with atherogenesis, which is 
when fatty deposits build up in the arteries and they become inflamed. It still 
remains unknown how diabetes contributes to atherosclerosis.  
 
Heat Shock Protein 60 (HSP60) is an important endogenous inflammatory 
mediator elevated in diabetic patients. HSP60 can be released from various 
cell types, including monocyte cells, which are the most common cell type 
found in atherosclerotic plaques. The mechanism behind how HSP60 
triggers endothelial cell inflammation remains unknown, but has been 
hypothesised to be similar to that of a Toll like receptor 4 ligand, 
lipopolysaccharide (LPS). Understanding the molecular mechanism of 
HSP60 could give insights into the pathological, cellular and molecular basis 
of vascular inflammation in diabetes as well as other vascular diseases such 
as cardiovascular disease.  
 
It is hypothesized that monocyte-derived HSP60 has a role in causing 
inflammation in the diabetic vasculature through the expression of pro-
inflammatory cytokines such as TNF-α, which could contribute to 
atherosclerosis. In this study a human monocyte cell line (Thp-1) was used 
to mimic monocyte behaviour. First a growth curve was established, which 
indicated when the cells were in their exponential phase. This enabled RNA 
to be extracted during the period when cells were growing the fastest.  
 
Thp-1 cells were then exposed to LPS for 6, 12, and 24 hours to determine 
the expression of TNF-α. After conducting RT-PCR, a 12 hour time point 
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was selected. Since inconsistent results were obtained using this semi-
quantitative analysis, qPCR was carried out for the rest of the project.  
 
Thp-1 cells were then exposed to 50ng/mL and 100ng/mL of LPS for 12 
hours. After conducting and analysing qPCR using the delta-delta Ct 
method and the Pfaffl method, a ~2 fold increase was seen in the expression 
of a pro-inflammatory cytokine, TNF-α. These results however were not 
significant (determined by a Student’s T test).   
 
In order to obtain a higher level of TNF-α expression, this experiment was 
repeated with 10ng/mL and 50ng/mL of LPS for 4 hours, based on previous 
published research. These results were analysed using the delta-delta Ct 
method and the Pfaffl method. The results were not what was expected; 
only an insignificant <1 fold increase was seen in the samples.  
 
Thp-1 cells were also exposed to 500ng/mL and 1500ng/mL of HSP60 for 
4 hours in order to see a TNF-α induction. HSP60 has been hypothesised 
to work through the same mechanism as LPS to trigger TNF-α , leading to 
an inflammatory response. However again, no significant increase in 
expression was seen (as determined by a Student’s T test).  
 
The inability to detect a significant up-regulation of the expression of TNF-α 
at mRNA level with LPS (positive control) and HSP60 in Thp-1 cells was 
surprising as this is well documented in the literature. This could possibly 
have been due to the high passage number of the Thp-1 cell cultures used 
in this study; mycoplasma contamination or stability of the LPS used.  The 
study therefore needs to be repeated with cells of a lower passage number 
and cells checked for mycoplasma contamination to establish appropriate 
time frames of exposure and concentrations of LPS and HSP60 required to 
see a TNF-α  induction. This could then be followed by experiments using 
receptor antagonists, such as TAK-242, (a TLR4 antagonist) to determine if 
TNF-α  expression levels would give an indication of whether or not HSP60 
was using the same pathway as LPS, and if it indeed played a part in 
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1 Literature Review 
 
 Statistics  
An estimated 451 million people worldwide have Diabetes Mellitus as of 
2017, with type 2 diabetes being the most common metabolic disease in the 
world  (Cho et al., 2018, Lowell and Shulman, 2005, Marett, 2014). This 
increasingly common disease is one of the leading causes of death 
worldwide (World Health Organisation, 2016), and the number of patients 
continues to increase every day. According to the International Diabetes 
Federation, by 2035 there will be an estimated 500 million diabetic patients 
worldwide. In 2012 1.5 million deaths were caused by diabetes and an 
additional 2.2 million caused by an increased blood glucose level, which 
lead to an increase in the risk of cardiovascular diseases (World Health 
Organisation, 2016). Type 2 diabetic patients have a 2-3 times higher risk 
of cardiovascular disease, which accounts for 50-80% of deaths in diabetic 
patients (World Health Organisation, 2011). People with diabetes are at risk 
of developing various life-threatening health problems, which results in 
higher medical care costs, reduced quality of life, and an increased mortality 
rate.  
 
Diabetes is increasing rapidly in low and middle income countries (World 
Health Organisation, 2016). The estimated global healthcare expenditure 
for diabetes is estimated to be around USD 727 billion, and is set to increase 
over the coming years (Cho et al., 2018). In New Zealand alone around 
257,000 people are diagnosed with diabetes and another 100,000 have 
undiagnosed diabetes (with type II being the most common form).  Maori 
and Pacific islanders are three times as likely to get diabetes as other New 
Zealanders. South Asians are also more prone to develop this disease. New 
Zealand, like the rest of the world, sees an increase in the number of 
diabetic patients and the largest increase is seen in type 2 diabetes related 
to obesity (Ministry of Health, 2018). This increase can be correlated to the 
changes towards a sedentary lifestyle that has come about due to rapid 
changes and urbanisation. Diabetes and its link with cardiovascular 
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diseases is the main cause of death in New Zealand (Ministry of Health, 
2018). Cardiovascular diseases are the main cause of death worldwide.   
 
 Diabetes Mellitus definition  
Diabetes mellitus is a chronic disease characterized by hyperglycaemia 
(high blood sugar) (Polonsky, 2012). Diabetes occurs when the hormone 
insulin is not produced at the regular rate (3.9-7.8mmol/L) (Diabetes Self-
Management, 2017). Insulin is responsible for regulating glucose in the 
bloodstream. In a healthy body, glucose consumed from food is broken 
down into ATP and used as energy. However, if enough insulin is not 
produced, or if the insulin present is not active, it results in an excess of 
glucose in the bloodstream (World Health Organisation, 2016). The 
prolonged hyperglycaemic condition creates a range of metabolic disorders 
that can cause generalised vascular damage that can affect the eyes, heart, 
kidneys and nerves (Cho et al., 2018). There are 4 types of diabetes; type 
1, type 2, gestational diabetes (common during pregnancy), and diabetes 
due to causes such as diseases of the exocrine pancreas. The most 
common types of diabetes are type 1 and type 2 (American Diabetes 
Association, 2012).  
 
Type 1 diabetes has a strong genetic basis and occurs due to destruction 
of the pancreatic beta cell, which produces insulin. This leads to less insulin 
being produced, and therefore glucose is not regulated in the body. Type 2 
diabetes, the most common form, deals with a decrease in the production 
of insulin as well as a decrease in insulin’s ability to take up glucose 
(Olokoba et al., 2012). This depends on the interplay between skeletal 
muscle responsiveness to glucose, and glucose stimulated insulin 
production via the pancreas (Lowell and Shulman, 2005).  Although it has 
some genetic basis, it is seen commonly in people who are overweight and 
who have a sedentary lifestyle with high fat and high calorie diets, which is 
becoming increasingly common today (Polonsky, 2012).  It is also becoming 
clear that type 2 diabetes is associated with progressive destruction of 
pancreatic beta-islet cells thorough autoimmune processes linked to 
inflammation (Juwono and Martinus, 2016). Not only does diabetes lead to 
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a decreased quality of life, it has also been named a precursor to 
cardiovascular disease, the leading cause of death worldwide.  
 
 Diagnosis 
The World Health Organisation’s conditions for diagnosing diabetes are 
summarised in the table below. Pre-diabetes is an intermediate and 
prolonged stage that leads to type II diabetes. Through altering diet and 
lifestyle, the progression to diabetes can be slowed down (Inzucchi, 2012).  
 
Table 1.1 Diabetes diagnosis tests 
Test Prediabetes / Impaired glucose regulation Diabetes 
Fasting plasma glucose 110-125 mg/dl ³126 ml/dl 
2 Hr plasma glucose 
(Oral Glucose Tolerance 
Test) 
140-199mg/dl ³200mg/dl 
Glycated hemoglobin - ³6.5% 
Random plasma glucose - ³ 200 mg/dl 
 
A fasting plasma glucose test requires that an individual fasts for 8-10 hours, 
followed by a blood glucose test. The OGTT requires a blood test to be 
taken in the morning before any consumption of food. Then the individual 
consumes a fluid with 75g of glucose, and after 2 hours glucose is measured 
in the blood again (Diabetes New Zealand, 2016). These are the two most 
common tests used for diagnosing diabetes (World Health Organisation, 
2011). Another more recent test is measuring the glycated haemoglobin in 
the blood. This is a measure of the glucose in the blood over the past 2-3 
months. An increase in glycated haemoglobin correlates to some of the 
complications in diabetes such as nephropathy, retinopathy and neuropathy 
(Stolar, 2010).  
 
 Symptoms 
Some of the symptoms hyperglycaemia induces are excessive thirst, 
frequent urination, weight loss and blurred vision. Diabetic patients are also 
highly susceptible to certain infections such as yeast infections (American 
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Diabetes Association, 2014). Long term complications include both 
microvascular and macrovascular problems (King and Grant, 2016), such 
as retinopathy and autonomic neuropathy (which can lead to cardiovascular 
symptoms). The chronic hyperglycaemic condition of diabetics is also 
associated with dysfunction, long-term damage and failure of organs such 
as the kidneys, eyes, nerves, heart and blood vessels (Inzucchi et al., 2010). 
Diabetic patients have an increased rate of atherosclerotic cardiovascular 
disease (American Diabetes Association, 2014), however, the actual cause 
for this remains unknown (Shah and Brownlee, 2016). This with be 
discussed further in Chapter 1.7 and onwards.  
 
In addition to medical symptoms, diabetes can bring about a lower quality 
of life and a large economic loss to the patients as well as to health systems 
and national economies (World Health Organisation, 2016). WHO has 
named diabetes as one of the four priority non-communicable diseases, 
including cardiovascular disease, cancer and chronic respiratory diseases 
(World Health Organisation, 2016). With the burden of diabetes increasing, 
it has become essential to understand this disease and its complications in 
order to reduce or slow down the rate of diagnosis in the world today. 
 
 The effects of hyperglycemia  
A prolonged hyperglycaemic condition in the body can lead to ill effects on 
the body such as the over production of free radicals, endothelial 
dysfunction and inflammation. These can result in other disorders such as 
renal disease and cardiovascular diseases.  The effects of hyperglycemia 
will be explained in this section.  
 
 Oxidative Stress  
Reactive oxygen species (ROS) highly are reactive molecules that are 
generated through normal cell metabolic processes and environmental 
factors such as cigarettes smoke. They alter cell structures such as proteins 
and nucleic acids by damaging them. Regulating the amount of ROS 
produced is necessary to ensure cell viability, activation, proliferation and 
function. This is done through enzymatic and non-enzymatic antioxidants 
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that are able to block the damaging effects of ROS.  In some pathological 
conditions including diabetes and atherosclerosis, the antioxidant systems 
are overwhelmed, either due to the excess of ROS produced or the 
pathological condition itself. This shift in which there are more harmful 
oxidants present in an organism than antioxidants is termed ‘oxidative 
stress’ (Birben et al., 2012). 
 
ROS are produced by enzymes that use oxygen as an electron acceptor, 
including NADPH oxidase, NOS and xanthine oxidase. These three 
enzymes are responsible for the majority of ROS in the vascular wall. ROS 
are chemically instable and highly reactive. They act as secondary 
messengers in the production of inflammatory mediators and regulate redox 
sensitive genes, such as the NFκβ gene. They affect various cell processes 
such as apoptosis, hypertrophy, extracellular matrix modification and 
mitosis (Gomes, 2013). 
 
When there is an excess of glucose in the bloodstream, different pathways 
become activated for metabolism. These include the polyol and protein 
kinase C (PKC) pathways which are not only related to the complications of 
diabetes, but also trigger an increase in ROS production. In normal 
conditions, around 3% of glucose goes through the polyol pathway. This is 
when glucose is converted to sorbitol via NADPH oxidation, followed by the 
conversion of sorbitol to fructose via NAD+ reduction. However, in 
hyperglycaemic conditions almost 30% of the glucose passes through the 
polyol pathway (Funk et al., 2012). This results in a loss of NADPH and 
glutathione, which increases the sensitivity to oxidative stress. Furthermore, 
when sorbitol is metabolised to fructose via sorbitol dehydrogenase, the 
ratio of NADH / NAD+ increases, resulting in the de novo synthesis of 
diacylglycerol (DAG) (Rolo and Palmeira, 2006). Increased amount of DAG 
also activates the PKC pathway, which leads to many diabetic complications 
such as capillary and vascular occlusion via increased pro-inflammatory 
gene expression through the expression of NF-κβ. This pathway also leads 
to an increased amount of NADPH oxidases, leading to an further increase 




The formation of advanced glycation end products (AGEs) also increase 
oxidative stress in diabetic patients. AGEs are formed when glucose reacts 
with a free amino group, which rearranges to form a product that 
accumulates on proteins. This starts off the process of advanced glycation 
and the resulting products are able to modify protein function and produce 
ROS (Rolo and Palmeira, 2006).  
 
Under normal conditions, once glucose is released into the bloodstream, it 
is taken into the cytoplasm of cells and converted into pyruvate thorough 
glycolysis. It then moves to the mitochondria and goes through the citric acid 
cycle (TCA), generating NADH. These substrates move through the redox 
carriers in the ETC, complex I, III and IV, to lastly to molecular oxygen, 
where it is converted to water. However, during this process incomplete 
reduced forms of oxygen are produced which leak from the mitochondria. In 
normal conditions only 0.1% of the oxygen leaks to generate ROS. The 
generation is primarily dependant on the redox state of the ETC; as 
electrons transfer through the chain, a proton / voltage gradient in generated. 
This goes on to generate energy in the form of ATP.  
 
In hyperglycaemic conditions when there is an increased generation of 
electron transfer donors such as NADH and FADH2, there is an increased 
influx into the ETC. This hyperpolarises the proton gradient, leading to an 
accumulation of electrons. This then drives the generation of ROS (Rolo 
and Palmeira, 2006). The mitochondrial hyperoxide ion may initiate events 
that lead to the activation of the NF-κβ pathway and increases the 
production of inflammatory cytokines (Gomes, 2013). The NF-κβ pathway 
will be discussed further in Chapter 15.  
 
These processes lead to an imbalance in ROS and the antioxidant defence, 
resulting in an overall increased oxidative state. In normal conditions an 
increase in ROS results in an increased expression of antioxidant enzymes, 
such as Cu-Zn superoxide dismutase, catalase and glutathione peroxidase. 
This is not seen in diabetic conditions; in type 1 diabetic patients, 
hyperglycaemia indicted increased lipid peroxidation, however the 
antioxidant enzyme was not induced, showing that although that although 
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the oxidative stress had increased, diabetic individuals were unable to 
generate a stronger antioxidant response (Gomes, 2013).  
 
 Hyperglycaemia and endothelial dysfunction 
There are many ways in which hyperglycaemia can cause endothelial 
dysfunction, several of them being the activation of certain metabolic 
pathways. The activation of these pathways are most likely the result of 
oxidative stress through the generation of ROS in the mitochondria (Van 
den Oever et al., 2010).  
 
As explained in Chapter 1.5.1, hyperglycaemia can induce the protein 
kinase C pathway (PKC) and this has several effects on vascular function. 
These include dysregulation of vascular permeability in smooth muscle, 
dysregulation of blood flow and base membrane thickening (Van den Oever 
et al., 2010).  
 
AGEs can accumulate in plasma and tissue and proteins modified by these 
products cause increased blood flow, increased capillary permeability and 
vasodilation. AGEs have the ability to increase endothelial permeability and 
decrease arterial elasticity. Collagen modified by AGE prevents normal 
matrix formation and cross-linking. AGEs in the bloodstream are detoxified 
by enzymes, however when they are not eliminated by the kidneys they can 
generate new AGEs and react with plasma and tissue components, leading 
to the deterioration of tissues (Van den Oever et al., 2010).  
 
 Hyperglycemia and inflammation 
As explained earlier, it has become increasingly clear that diabetes is linked 
to inflammation and the progressive destruction of beta islet cells through 
autoimmune processes. Autoimmunity can be seen in a large number of 
pathological conditions including diabetes. Autoimmunity is a complex 
multifactorial process that results in the loss of self-tolerance and a chronic 
excess reactivity of B and T cells, resulting in danger signals being released 
in the body. Danger signals being released results in the production of 




The mitochondria play a key role in secreting insulin from the B-islet cells, 
once glucose has been detected in the bloodstream. A protein called Heat 
Shock Protein 60 (HSP60) is released from the mitochondria when under 
stress or when the mitochondria is impaired. This protein is able to activate 
a signalling cascade through the activation of Toll-Like Receptors, leading 
to the production of pro-inflammatory cytokines, such as TNF-α and IL-1 
and IL-6. TNF-α is also involved in insulin resistance and therefore 
propagates the condition of diabetes, as well as causing inflammation 
(Gomes, 2013; Juwono et al., 2016). This pathway will be discussed in detail 
in Chapter 1.8. 
 
 Heat Shock Proteins (HSPs) 
As their name suggests, HSPs were first discovered by chance when they 
were expressed due to increased temperature (Grundtman et al., 2011). 
HSPs are highly conserved proteins in both prokaryotic and eukaryotic cells. 
They are involved in the maintenance of many cellular proteins, such as 
transporting, intracellular folding and unfolding of proteins (Wick et al., 2014). 
Under normal conditions, HSPs are responsible for assisting organisms 
during protein folding and refolding (Xu et al., 2012). Each type of HSP have 
different roles in the process of protein folding and unfolding, and overall 
they work to maintain protein structure and function (Xu et al., 2012). HSPs 
are categorised based on their size, ranging from small HSPs to HSP110 (5 
kDa to over 100kDa) (Grundtman et al., 2011). They can be classified into 
six major families that are present in different cellular compartments, 
summarised in the table below. When cells are under physiological stress, 
such as high temperatures or hyperglycaemia, the expression of these 
proteins are increased (Wick et al., 2014). While they may be relatively 
temperature stable, many proteins are sensitive to sudden environmental 
changes and will begin to unfold and deform under stress. Since organisms 
must try to survive in a diverse range of conditions, HSPs act as a protecting 





Table 1.2 Heat Shock Protein families size and locations (Adapted from Itoh 
et al., 2002) 
Family Size Localisation 
sHsps 12 Cytoplasm and nucleus 
Hsp40 43 Cytoplasm and nucleus 
HSP60 60 Mitochondria and cytoplasm 
Hsp70 70 Cytoplasm, nucleus and ER 
Hsp90 90 Cytoplasm and ER 




HSP60 is a highly conserved ring shaped mitochondrial stress protein. 
Within bacterial species there is 95% homology of HSP60 at the DNA and 
protein level, and up to 72% homology between human and bacterial 
species (Grundtman et al., 2011, Juwono and Martinus, 2016). It works in 
an ATP-dependent manner, encapsulating non-native proteins and aiding 
them with folding into the correct shape (Xu et al., 2012). This protein is 
expressed in the mitochondria and during stressful conditions can be 
translocated to the cytosol and cell surface to be exposed to the 
extracellular environment (blood plasma) (Grundtman et al., 2011).  
 
The most studied member of the HSP60 family is the GroEL protein found 
in E. Coli, which aids in protein folding. It works together with its co-factor 
GroES, also known as Hsp10, in an ATP dependent manner to assist with 
protein folding (Hansen et al., 2003). A GroEL monomer contains 3 domains; 
Apical, Intermediate and Equatorial. 14 of these identical subunits assemble 
into two heptameric rings stacked back to back. GroES has 7 identical 
subunits that form a heptameric ring. There are two main conformational 
states of GroEL-GroES, with ATP being converted between the states. First 
GroEL binds a non-native polypeptide to its centre through hydrophobic 
contacts, and then expands and shields itself from the external area, 




 Cardiovascular diseases: Major complication in 
diabetics 
The leading cause of death in diabetic patients are cardiovascular diseases 
(International Diabetes Federation, 2018). Cardiovascular disease is a 
collective term for the diseases of the blood and heart vessels. They include 
microvascular diseases such as renal disease, various neuropathies, and 
macrovascular diseases, mainly covering atherosclerotic incidents such as 
myocardial infarction and strokes (Brownlee, 2001). Diabetic patients have 
a 2-4 fold increase in the risk of cardiovascular dieases compared to healthy 
individuals. After diagnosis, their prognosis is significantly worse than that 
of cardiovascular disease patients without diabetes (King and Grant, 2016).  
 
The causes behind these diseases include high blood pressure, high blood 
glucose levels or a poor dietary intake. In an unhealthy lifestyle many young 
people lead today, the prevalence of both diabetes and cardiovascular 
diseases is set to increase. Cardiovascular diseases are usually identified 
and diagnosed after a patient has had a stroke, showing that these diseases 
go undetected until medical treatment becomes necessary, not giving the 
patient a warning or a chance to improve their lifestyle (American Heart 
Association, 2016). However, it has become clear that people diagnosed 
with diabetes can reduce or slow down the onset of this disease, which in 
turn would help to slow down the onset of cardiovascular diseases.   
 
A link between diabetes and cardiovascular disease has been recognized 
for decades (Funk et al., 2012). It becomes important to understand the 
pathological basis of this link in order to allow us to create any possible 
protective measures against them. The hyperglycaemic condition in 
diabetes has been proven to contribute to atherosclerosis. The exact details 
of how this occurs remains unknown, however there has been much 
speculation, including the production of free radicals and the overexpression 




 Atherosclerosis  
Atherosclerosis is responsible for over 80% of deaths and 75% 
hospitalizations in diabetic patients (Basa and Garber, 2001). 
Atherosclerosis is a condition that occurs when materials such as 
cholesterol, lipids and inflammatory cells are deposited in the endothelium 
of arteries in the heart (King and Grant, 2016). The arterial wall is part of the 
circulatory system and is remodelled continually when exposed to stressors 
including toxins and hypercholesterolemia. Stimuli like these are able to 
create a change in blood pressure and damage the vessel wall, which leads 
to arterial stiffness and starts the onset of atherosclerosis (Xu et al., 2012). 
This leads to plaques forming, which can cause myocardial infarction, stroke, 
unstable angina and lower limb ischemia (King and Grant, 2016). 
Atherosclerosis leads to the diagnosis of various other cardiovascular 
diseases, as it begins to block off the arteries.  
 
 The possible effect of HSP60 in Cardiovascular diseases  
HSP60 is the only heat shock protein that shows a direct link to 
atherosclerosis through experimental and clinical trials (Wick et al., 2014).  
The movement of this protein to the cell surface has been recognised as a 
stress response and correlates strongly with the development of 
cardiovascular disease (Grundtman et al., 2011). Several researches have 
been conducted that support that HSP60 has a big role in the development 
of atherosclerosis which will be further explained below.  
 
A study carried out by Yuan et al in 2011 revealed that diabetic patients 
have elevated levels of HSP60 in saliva and serum, which could be a 
contributing factor to the development of atherosclerosis and plaque 
formation (Yuan et al., 2011). In Type 2 diabetic patients, salivary HSP60 
was found to be 4 fold higher and serum HSP60 16 fold higher than non-
diabetics (Juwono and Martinus, 2016). In a recent paper published by 
Martinus and Goldsbury in 2017, it was clearly demonstrated that when Thp-
1 cells were grown in the presence of glucose 25mM glucose, HSP60 





Xiao et al. proposed that HSP60 was involved in activating pro-inflammatory 
processes (discussed below), which is a key factor in atherogenesis (Xiao 
et al., 2005). HSP60 is able to activate both the innate and adaptive immune 
system (Schoneveld et al., 2008). It is also able to act as a ligand for innate 
immune receptors and is recognized as an antigen by adaptive immune 
receptors (Juwono and Martinus, 2016). Humans acquire immunity against 
bacterial HSP60 through infection or vaccination, however this defence can 
increase the risk of cross-reactivity with HSP60 produced by stressed 
endothelial cells, such as those of the arteries under hyperglycaemic 
conditions (Wick et al., 2014). It has been shown that when endothelial cells 
are exposed to stress, HSP60 is released into the supernatant. HSP60 is 
then able to activate Toll-like receptors (TLRs) and trigger a cascade of 
reactions that lead to an inflamed state (Tian et al., 2013).  
 
 Toll-Like Receptors (TLRs) 
The innate immune system contains a group of Pattern Recognition 
Receptors (PRRs) called TLRs that sense the presence and type of an 
invading pathogen. They initiate a rapid antimicrobial response and allow 
the development of adaptive immunity specific for the detected pathogen 
(Makkouk and Abdelnoor, 2009).  
 
TLRs were first discovered in the fruit fly (Matsunaga et al., 2011) and were 
found mainly to be involved with the body development of the fly. Later they 
were discovered in mammals, however it was noted they had no role in 
development, but played an important part of the innate immune system. 
TLRs are a group of highly conserved glycoproteins located intracellularly 
or on the surface of many cell types, such as B cells, monocytes, regulatory 
T cells, respiratory epithelial and endothelial cells. They recognise Pathogen 
Associated Molecular Patterns (PAMPs), which are sets of specific 
pathogen components shared by groups of (invading) microorganisms 
(Makkouk and Abdelnoor, 2009). PAMPs act as exogenous ligands for 
TLRs, and when they come into contact with specific TLRs, they sets of a 
signalling cascade. In humans 10 TLRs have been identified (Tian et al., 
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2013) and each become activated by different PAMPs (Makkouk and 
Abdelnoor, 2009; Juwono and Martinus, 2016). TLR 1, 2, 4, 5, 6, and 10 are 
located on the cell surface and the rest intracellularly. TLRs contain two 
significant domains; a ~ 25 tandem leucine-rich repeat motif which is the 
external antigen recognition domain, and a cytoplasmic domain made up of 
200 amino acids called the Toll interleukin-1 resistance (TIR) domain. These 
two domains are attached to one another by a transmembrane helix, which 
is sometimes referred to as the third domain (Patra and Choi, 2016) 
(Makkouk and Abdelnoor, 2009). 
 
Table 1.3 Toll-Like receptors location and ligands (Adapted from Makkouk 
and Abdelnoor, 2009) 
TLR Location Exogenous PAMPs 
1, 2, 6 Cell surface Lipopeptides 
4 Cell surface LPS 
3 Intracellular dsRNA 
7, 8 Intracellular ssRNA 
9 Intracellular Non-methylates CpG DNA 
5 Cell surface Flagellin 
 
TLRs sense the invasion of microorganisms through PAMPs and respond 
by triggering a range of defence mechanisms (Juwono and Martinus, 2016, 
Makkouk and Abdelnoor, 2009). TLRs can recognize their endogenous 
ligands, as well as proteins that are released due to cellular stress (Wong 
and Wen, 2008) such as HSP60. TLR2 and TLR4, which are both 
upregulated in diabetic patients, can be activated by recognising PAMPs on 
their ligands such as HSP60, HSP70, endotoxins (LPS) and AGEs. Once 
activated, TLRs homodimerize or heterodimerize, and recruit adaptor 
proteins (Patra and Choi, 2016). This activates one of two distinct pathways 
that are dependent on either the adaptor proteins myeloid differentiation 
factor 88 (MyD88) or Toll/IL-1 receptor (TIR)-domain-containing adaptor 
protein inducing interferon (IFN)-β-mediated transcription factor (Trif). This 
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leads to the activation of nuclear factor-kb and IFN regulatory factors, 
ultimately leading to the production of inflammatory cytokines  such as IL-b, 
IL-8 and TNF-α (Tian et al., 2013) (Juwono and Martinus, 2016). All TLRs 
signal using the MyD88-dependant pathway except for TLR3. TLR4 uses 
the Trif pathway to a certain extent once activated, however TLR2 does not 
(Tian et al., 2013).  
 
A study carried out by Devaraj et al (2009), and Dasu et al (2010) 
demonstrated that diabetic patients have an increase in circulating TLR 
levels, in particular TLR2 and TLR4.   They also have an  increase in HSP60, 
which TLR2 and TLR4 can use as a ligand (Tsan and Gao, 2004). Due to 
the increase of expression in TLR2 and TLR4, an increase in inflammation 
was observed. This was mediated by the NF-kb pathway. Dasu et al. also 
found increased concentrations of pro-inflammatory mediators such as IL-
1B, IL-6, IL-8, MCP-1 and TNF-α. 
 
 TLR Receptor agonists and antagonists  
TLR agonists are small molecular mimics of the natural ligands of TLR 
receptors. The aim of these agonists is to ultimately lead to the production 
of cytokines by stimulating signal transduction pathways. Mimics of natural 
microbial ligands have been created that have enhanced pharmacokinetic 
and pharmacodynamic properties compared to the natural ligands. Some 
agonists used so far include imiquimod and resiquimod, which are able to 
activate TLR7 as they mimic its ligands. TLR7 agonists have been used to 
target disorders caused by papillomavirus. Another agonist is LPS for TLR4. 
LPS is an outer membrane glycolipid constituent of Gram negative bacteria. 
It has three portions; a hydrophobic lipid A component, a hydrophilic core, 
and an O-antigen, which are all covalently linked. LPS however can’t be 
used medically as it is toxic, but it has been found to stimulate TLR4, which 
is useful for research purposes (Makkouk and Abdelnoor, 2009). As 
explained above, TLR2 and TLR4 both go through the MyD88 pathway and 





TLR antagonists are usually structural analogs of agonists and can bind to 
the TLR receptors, but they do lead to signal transduction as they are not 
able to induce the structural rearrangement required. This means that the 
usual signal transduction pathway is not activated and therefore no 
inflammatory cytokines are produced (such as TNF-α) (Makkouk and 
Abdelnoor, 2009, Patra and Choi, 2016). To date antagonists developed to 
inhibit or reduce TLR signalling include aptamers, oligonucleotides, 
peptides, antibodies, proteins and small molecules. TLR antagonists can 
target the different domains of the TLR receptor itself, or can work in an 
indirect way, such as by interacting with receptor agonist and reducing their 
ability to activate their receptors (Patra and Choi, 2016).    
 
 Importance of monocytes 
Monocytes are leukocytes derived from bone marrow progenitor cells. They 
were one of the first cells to be identified in atherosclerotic plaques (Moore 
and Tabas, 2011) (Woollard and Geissmann, 2010). Monocytes are 
recruited to areas dense with ApoB-LPs due to cytokines released from 
endothelial cells (Moore and Tabas, 2011). An accumulation of 
apolipprotein B containing lipoproteins (ApoB-LPs) has been identified as 
an initiating step in atherosclerosis, and blood-borne monocytes releasing 
HSP60 could be contributing to the inflammatory response. As inflammation 
increases, monocytes travel from the blood to lymphoid and non-lymphoid 
tissues and into the intima and sub intima. It is assumed that when they 
come into contact with fatty deposits, they undergo activation and begin to 
accumulate in the lesion where inflammation occurs. Here they are able to 
phagocytose toxic molecules as well as other cells, and are able to 
differentiate into inflammatory DCs, macrophages, or foam cells. (Woollard 
and Geissmann, 2010). This aids in the process of forming plaques, 
commonly called fatty streaks, inside the intima.  Fatty streaks indicate the 
beginning of atherosclerotic plaques (Woollard and Geissmann, 2010). For 
the process of atherosclerosis to continue, it is required that cells are 
continually recruited to the area. Through studies that use labelled 
monocytes and radioactive tracers, it has been shown that the monocyte 
number in the aorta is consistent with the surface area of the plaque 
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(Woollard and Geissmann, 2010), indicating the build-up of monocytes over 
time.  
 
Under some experimental conditions, some monocytes have been seen to 
emigrate from the plaques back into the bloodstream. With these 
differences it becomes apparent that there may be subsets of monocytes 
with different functions.  They can be distinguished partly by the different 
surface markers they express. A subset of monocytes has been found to 
turn into macrophages, while another set reside in the luminal side of the 
endothelium of small blood vessels during inflammation (in the brain, 
arteries in the dermis and mesentery). These types both express different 
surface markers, However, it is important to note that blood monocytes have 
been seen in the atherosclerotic plaques, and their role in this condition has 
not properly been elucidated (Woollard and Geissmann, 2010). 
 
In this research the Thp-1 cell line was used as an imitation for monocytes 
in the serum of diabetic patients. The thp-1 cell line originates from a 1 year 
old acute monocyte leukaemia patient  (Tsuchiya et al., 1980). Most of the 
studies so far have been conducted in mice, however human blood 
monocytes show similarities to the subsets of monocytes in mice(Woollard 
and Geissmann, 2010). 
 
 Macrophages 
Monocytes can differentiate into macrophages using differentiation factors 
including macrophage colony-stimulating factor (M-CSF) (Moore and 
Tabas, 2011). In early atherosclerotic plaques, a large percentage of 
monocytes become macrophages or dendritic cell like. Like monocytes, 
within the macrophages there are subsets in which some have been 
suggested to be involved in repair, while others in  pro-inflammatory 
processes (Moore and Tabas, 2011).  
 
These cells have many pattern recognition receptors, such as the 
scavenger receptors, which are known to connect the innate and adaptive 
immune response in the process of atherosclerosis. In particular, CD36, a 
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B scavenger receptor increases macrophage spreading, which inhibits their 
migration and essentially traps them in the arterial intima. Scavenger 
receptors are another important area that need to be elucidated concerning 
atherosclerosis (Woollard and Geissmann, 2010). 
 
Interestingly, although monocytes are recruited into the plaque, monocytes 
derived macrophages in the plaque may secrete apoB-LP binding 
proteoglycan. This may have a major role in LP retention in the plaque, 
which increases inflammation, promoting atherogenesis (Moore and Tabas, 
2011).  
 
  Project: Expression of TNF-α  at mRNA level in Thp-1 
cells exposed to LPS and HSP60: Possible impact on 
diabetic vascular inflammation 
It has been observed that HSP60 is present in high levels in the serum of 
diabetic patients. This may initiate pro-inflammatory cytokines in certain cell 
types through the interaction of TLR2 and TLR4 receptors, leading to non-
resolved vascular endothelial cell inflammation (Juwono and Martinus, 
2016). Since the prevalence of diabetes is increasing worldwide and this 
inflammation can lead to atherosclerosis, it is important to understand the 
connection between these two diseases in order to see if certain pathways 
can be blocked to slow down or reduce diabetic atherosclerosis. Research 
done around this topic so far suggests that HSP60 has a significant role in 
the development of diabetic atherosclerosis and this could provide a key 
missing link between diabetes and vascular inflammation.  
 
  Aims and objectives  
It is known that LPS induction of Thp-1 cells lead to an increased expression 
of the pro-inflammatory cytokine TNF-α through the interaction of TLR4. It 
has also been shown through research that HSP60, which is elevated in 
diabetic patients, may also be using TLR4 to induce a TNF-α response. 
Recently research has also emerged showing that HSP60 may also be able 
to trigger TLR2. HSP60 triggering the TLRs may be leading to an inflamed 
state in the arteries of the heart, contributing to the atherogenesis and the 
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development of cardiovascular diseases. It becomes of interest to 
understand the molecular mechanism of HSP60 to see whether this protein 
is causing diabetic vascular inflammation. The objectives of this project are 
described below.  
 
Objective 1: Establishing a Thp-1 cell growth curve and optimising RNA 
extraction  
This was achieved by growing Thp-1 (Human monocyte cell line) cells in 
RMPI growth media supplemented with fetal bovine serum and penstrep. 
Growth curves were carried out to determine the best time RNA should be 
extracted. RNA was extracted using the Trizol method. Quantity of RNA was 
determined by testing the sample using a nanodrop machine 
(Nanodrop2000,Thermo Fisher). Quality of the RNA was determined by 
running formaldehyde and agarose gels.  
 
Objective 2: Quantifying a TNF-α response from thp-1 cells  
This objective was achieved by exposing Thp-1 cells  to LPS, which is a 
ligand for TLR4 and can induce TNF-α induction. RNA was extracted and 
cDNA was synthesised. PCR for TNF-α and the house keeping gene 
GAPDH were carried out. The PCR products were visualised on a gel and 
the band intensities were compared using Thermo Fisher software on the 
iBright imaging system (Thermo Fisher) for conducting semi-quantitative 
analysis.  
 
Objective 3: Real Time PCR analysis of Thp-1 cells induced with LPS 
This objective was met by exposing Thp-1 cells to LPS for different time 
periods. RNA was extracted and cDNA was synthesised. Real time PCR for 
TNF-α and the house keeping gene GAPDH were carried out and the results 
analysed.  
 
Objective 4: Real Time PCR analysis of Thp-1 cells induced with 
extracellular Hsp60 to generate a TNF-α response  
Extracellular Hsp60 was exposed to the Thp-1 cells in order to trigger the 
TNF-α response. This was done by exposing different concentrations of 
HSP60 to Thp-1 cells for a certain time period. TNF-α induction was 
measured through qPCR and analysed.  
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2 Materials and Methods 
 
All methods were carried out at the University of Waikato, in either the E3.11, 
E3.13 (PC2 lab), or C.2.03. All experiments were carried out aseptically in 
areas cleaned with 70% ethanol. RNA work was done is designated areas 
specific for RNA work only.  
 
This chapter contains the general methods that were carried out repeatedly 
throughout this project. Individual experimental details are written in the 
methods section of each chapter.  
 
 Common solution preparations 
Table 2.1 Common solutions and compositions 
Solutions  Composition  
0.1% DEPC water  100ul of DEPC in 1L of MQ water  
MOPS buffer (10x) 
0.4 M MOPS – 8.37g 
0.1M Sodium Acetate – 0.82g 
Made up to 100mls with DEPC water, 
pH adjusted to 7 using NaOH 
RNA Loading Dye  
95% formamide 
0.025% SDS  
0.025% bromophenol blue  
0.025% xylene cyanol FF  
0.025% ethidium bromide  
0.5mM EDTA 
TAE buffer (50x) 
Tris base – 121g 
Glacial acetic acid – 28.55mL  
0.5M disodium EDTA- 50mL 
Tris was first dissolved in 300mL of 
DEPC water, then disodium EDTA and 
glacial acetic acid was added 
THP-1 cell media Gibco RPMI media with 10% fetal bovine serum and penstrep 
Tris-HCl buffer  
Tris – 121.4g 
HCl 
Tris was dissolved in 1L of MQ water. 
The pH was adjusted to 7.0 using 
concentrated HCl 





 Thp-1 Cell culture  
Frozen Thp-1 cells were obtained from the -80°C cell culture inventory in 
the Department of Biological Sciences at the University of Waikato. These 
cells were grown in RPMI media (Gibco) with 10% FBS and 500ul Penstrep 
(Gibco) at 10,000U/mL. These cells were kept in standard incubator 
conditions; 37°C, 5% CO2 in a humidified incubator. The cells were split 
every four days and topped up with fresh media to keep them healthy and 
growing.  
 
 RNA extractions for THP-1 cells 
This RNA extraction method was used on all cell lines. After obtaining a cell 
count of ~ 105 cells, the cells were centrifuged for 2000 rcf for 7 min to form 
pellets. After removing the media layer, .5mL of Trizol was added and the 
cell pellet was resuspended. This was left for 15 min, allowing the cells to 
lyse. 0.1mL of chloroform was added and the tubes were shaken vigorously 
for 20 seconds. This was left for three min, and then centrifuged at 12,000 
rcf for 15 min at 4°C. The layers were then separated; the clear upper 
aqueous phase was put into a separate 1.5mL RNAse/DNAse free 
Eppendorf tube. 0.5mL of isopropyl alcohol was added to this, and it was 
left for 10 min at room temperature, followed by 20 min at -20°C, to allow 
RNA to precipitate. This was then centrifuged at 12,000 rcf for 10 min at 4°C. 
Regardless of whether a pellet was seen, the supernatant was removed and 
1mL of 75% alcohol was added to was the precipitate. This was then 
centrifuged at 7600 rcf for 5 min at 4°C. The pellet was then air dried in the 
fume hood for 15 min. The pellet was resuspended in 20µl of DEPC water 
and stored at -80°C for further use.  
 
 Nanodrop readings 
After RNA had been extracted, 2uL of the sample was tested on the 
Nanodrop2000 (Thermo Fisher) machine to determine the quantity and 
quality of the RNA. Absorbance at 280nm is used as an indicator of the 
purity of nucleic acid samples. A 260/280 ratio of ~ 2.0 is accepted as pure 
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for RNA (Thermo Scientific, 2012). If the value is significantly lower (<1.8), 
it indicates contamination by residual phenol or reagents used in the 
extraction process. If the concentration of RNA extracted is very low (~ 
10ng/µL), the absorbance ratio cannot be determined accurately (Thermo 
Scientific, 2012). 
  
 cDNA synthesis 
The qScript XLT Supermix cDNA synthesis kit was used according to the 
manufacturer’s directions. Each reaction contained up to 1 µg of RNA, 2 µl 
of the supermix and DEPC water to reach a total volume of 10µl. This was 
run in PTC-200 Peltier Thermal Cycler at 25°C for 5 minutes, 42°C for 60 
minutes, 85°C for 5 minutes and held at 4°C.  After synthesis, cDNA was 
diluted 1:5 and 1:10 with DEPC water, which resulted in clear PCR product 
bands after PCR. 
 
 Primers 
Based on previous research, the primer pairs specific for GAPDH and TNF-
α were ordered from Sigma-Aldrich. These primers were supplied at 100uM. 
They were diluted down to 10uM (80uLs of DEPC water, 10uM forward 
primer and 10uL of reverse primer). The sequences and locations they bind 
are shown below in Figure 4.3 and 4.4. These primers were verified with the 
online database at GenBank to ensure that they matched the human genes. 
 
 
Table 2.2 Primer sequences and product sizes of GAPDH and TNF-α 
Gene Primer Sequence Product size (pb) 
GAPDH forward ACC ACA GTC CAT GCC ATC AC 
452 
GAPDH reverse TCC ACC ACC CTG TTG CTG TA 
TNF-α forward CAG AGG GAA GAG TTC CCC AG 
325 






  Figure 2.1 TNF-α forward and reverse primers showing position on TNF-α 






 2% Agarose gel electrophoresis 
The quality and quantity of the RNA was assessed using the Nanodrop2000 
(Thermo Fisher) as well as running the extracted RNA on a 2% agarose gel. 
The PCR bands were also visualised using 2% agarose gels. This was 
prepared by using 2g of agarose and 100mls of 1x TAE buffer. For staining, 
2ul of EtBr was added to the molten gel. A 100bp ladder (SolisBiodyne) was 
run alongside the samples to judge size of products. The gel was run for 










Figure 2.2 GAPDH forward and reverse primers showing position on 
GAPDH  gene and final product length of 452 bp. 
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3 Optimising Thp-1 cell culture and RNA 
extraction methods 
 
 Introduction  
Diabetes Mellitus is associated with high levels of mitochondrial stress 
protein HSP60 in the bloodstream. HSP60 is released from many cell types 
and is known to activate pro-inflammatory responses in target cells. This 
leads to the release of pro-inflammatory cytokines such as TNF-α (Chapter 
1.7.2). This upregulation initiated by HSP60 has been hypothesised to 
cause inflammation in diabetic patients, which can eventually lead to the 
formation of atherosclerotic plaques. It is known that one of the first cells 
and most common cells to be found in these plaques are blood borne 
monocytes. These cells are also able to differentiate into macrophages or 
foam cells in the plaque (Chapter 1.9).  
 
In this project the expression of TNF-α was to be measured in monocyte 
cells they after were exposed to LPS (a trigger that is well documented to 
lead to the expression of TNF-α), and HSP60. The cells used throughout 
this project were Thp-1 cells.  Thp-1 cells are a monocytic cell line originally 
derived from a leukaemia patient (Chapter 1.9). These cells were used to 
mimic monocyte behaviour in the bloodstream of diabetic patients.  
 
The first task of this project was to establish a growth curve for Thp-1 cells. 
This enabled subsequent RNA extractions to be undertaken during the 
exponential phase of growth, maximising the amount of RNA extracted. 









 Growth Curve 
Thp-1 cells were seeded at 105 cells (in approximately 2 mLs) into each well 
of a 6 well plate and incubated in a humidified CO2 incubator at 37°C 
(standard incubator conditions for cell growth). Cells from 2 wells were 
harvested every 24h and cell counts were done using trypan blue. An equal 
amount of cells and trypan blue solution was pipetted onto the 
haemocytometer and viewed under a phase contrast microscope (Nikon 
eclipse TS100). The haemocytometer has several grid areas. Cells in the  4 
outer 4 by 4 squares, and the middle square were counted. The volume in 
each of these areas can be represented as 1mm x 1mm x 0.1 mm = 0.1mm3. 
The total volume of the squares in which cells are counted is 0.1mm3 x 5 = 
0.5mm3. As 1mL volume = 1000mm3, the volume counted would be 1/2000 
of 1 ml (1000mm3 / .5 mm3 = 2000). Therefore, the total cell number from 5 
squares was multiplied by 2000 to give a final cells per mL count. Cells that 
took up the dye and appeared dark blue under the microscope were 
recognised as dead cells, and were not counted when determining cell 
number.  
 
 RNA extraction 
RNA extraction was carried out using the TRIzol method as described in 
Chapter 2.3. 2uL of the samples were then tested on the Nanodrop, with an 
expected 260/280 ratio of ~2, as described in Chapter 2.4.  
 
 Visualising RNA using Formaldehyde gels 
1g of agarose was added to 72ml of DEPC water. This was heated in a 
microwave until boiling, and agarose was fully dissolved. After cooling to 
approximately 60°C, the flask was transferred to a fumehood where 10x 
MOPS buffer and 18ml of 73% formaldehyde were added. RNA samples 
were run at varying concentrations (1800ng, 1350ng, 675ng, 225ng) on the 
gel with 10x MOPS buffer for approximately 1 hour and 20 minutes and the 




  Visualising RNA using Agarose gels 
This method is described in Chapter 2.6 and was used throughout the rest 
of the project.  
 
 Results  
 Phase Contrast Images of Thp-1 cells 
  
Figure 3.1 Thp-1 cells growing in standard conditions (RMPI supplemented 
with FBS and Penstrep). A: 40x magnification, B: 10x magnification. 
 
The cells seen above show healthy Thp-1 cells, as the membranes are 
intact and well defined. They appear to be circular in shape and often grow 
in little clusters as seen in the second figure. They appear like this before 














 Growth Curve 
 
Figure 3.2 Growth curve for Thp-1 cells over the period of 7 days. 
 
The growth curves show a lag phase straight after cells have been seeded 
at approximately 5000 cells per well in a 6-well plate, showing that at this 
point the cells have just begun to slowly divide. This is followed by the 
exponential phase of growth around day 3 when there are ~10,000 cells 
growing at its fastest rate. Around day 5 the growth curve begins to plateau, 
showing that cell growth has significantly slowed down. RNA should be 
extracted around day 3-5 as this is when the cells are growing the fastest 
by using the environment around them for nutrients, before reaching the 
stationary phase when the nutrients have been exhausted.  
 
 RNA quality and quantity  
 
Table 3.1 RNA concentration and 260/280 ratio of control Thp-1 cells 
Sample RNA concentration (µg/mL) 260/280 
Control sample A 201.6 2.09 


























The table above shows the concentrations of the RNA extracted were 
201.6ng/mL and 454.7ng/mL. This initial experiment was carried out two 
times as seen above (N=2). The RNA concentration and 260/280 ratio was 
considered sufficient. Ideally the 260/280 ratio is expected to be ~2, which 
is seen in both samples.  
 
 RNA integrity 
 
Figure 3.3 Formaldehyde gel run for 1 hour and 
20 min at 80V with sample A (600µg/mL RNA) 




Figure 3.4 2% Agarose 
gel run for 1 hour and 
20 minutes at 70 V with 
sample B. Lanes shown 
A: 1800µg RNA. B: 
1350µg RNA, C: 675µg 




RNA integrity refers to the tertiary structure of the RNA as it travels through 
the gel. If the structure is altered, the bands appear to be smudged on the 
gel. There are two distinct RNA bands that can be visible on a gel; 28S and 
18S (with the numbers referring to their sizes). Initially RNA extracted from 
control cell (cells grown in growth media supplemented with 10% FBS and 
Penstrep (Gibco) under standard incubator conditions) were run on both a 
formaldehyde gel and a 2% agarose gel to assess which would be more 
suitable for this project. A formaldehyde gel is commonly used for visualising 
RNA as the formaldehyde acts as a denaturing agent, allowing the two RNA 
bands, 28S and 18S to separate and become clearly visible on the gel. 
Formaldehyde can also act as an RNAse inhibitor, which helps to maintain 
the RNA during handling (Mansour and Pestov, 2013). However, as seen in 
Figure 3.3, in the formaldehyde gel the two RNA bands are difficult to see. 
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This may have been because of the quality of the gel made, or because the 
amount of RNA loaded was not enough to show on the gel. In Figure 3.4, a 
2% agarose gel was loaded with RNA at different concentrations (1800ng, 
1350ng, 675ng, 225ng). This was done to assess how much RNA (in ng/mL) 
should be loaded in order to see clear bands, as well as to assess the 
integrity of the RNA. Even at a very low concentration of ~200ng of RNA, 
bands are visible.  
 
 Discussion  
The objectives of the experiments detailed in this chapter were to generate 
a growth curve for thp-1 cells, and become familiarised with the RNA 
extraction process in order to extract sufficient and useable RNA in the 
following experiments. THP-1 cells were cultured under standard growth 
conditions in a humidified CO2 incubator at 37°C. Generating a growth curve 
gives insight into the phases of growth in a cell culture. A cell culture 
generally goes through phases called a lag phase and a logarithmic phase, 
after which it will go into plateau and reach a stationary phase. The lag 
phase occurs at the beginning as the cells slowly start to grow. The 
exponential phase is when the cells are duplicating and this is the best time 
to extract RNA as the cells are actively growing and using the environment 
around them to aid growth. When the cells growth begins to plateau, it 
indicates that the media has been exhausted (van Meerloo et al., 2011). 
Monitoring the viable cell number (using Typan blue staining) every 24h 
during a 5 day growth study enabled the construction of a growth curve for 
THP-1 cells.  When cells were seeded at 5000 cells per mL they remained 
in a lag phase for 2 days, exponential phase during ~ 2 days and reached 
stationary phase after 4 days.  Repeating this growth study gave similar 
responses (Figure 3.2).  
 
The TRIzol method was used to extract RNA. TRIzol reagent is a solution 
containing phenol and guanidine isothiocyanate. When the cells and cellular 
components lyse, TRIzol reagent maintains the integrity of the RNA. After 
TRIzol reagent has been added and the samples have been incubated, 
chloroform is added and the samples are spun in the centrifuge. This allows 
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two layers to be formed; an upper aqueous phase and lower organic phase. 
The upper phase contains RNA and is separated from the organic layer and 
precipitated with isopropanol. The lower organic phase contains DNA and 
proteins (which can be precipitated with ethanol to yield DNA, and 
precipitated further to yield proteins) (Simms et al., 1993). This method 
resulted in RNA with a 260/280 ratio between 1.9-2.10, as well as clear 
bands that can be seen in Figure 3.5. If the ratio was well below 1.8, it would 
indicate contamination by the reagents used, leaving behind guanidine or 
residual phenol in the extracted samples (Thermo Scientific, 2012). This 
showed that the TRIzol method was successful and that the RNA for the 
coming experiments can be extracted using this method. Although quality is 
measured using the 260/280 ratio through the Nanodrop, it is important to 
note that DNA is also able to absorb around 260nm. This means that 
although RNA is present, it may be contaminated with DNA. To further 
assess the RNA samples by looking at their integrity, they were run on gels. 
 
To assess the integrity of the bands, RNA could be run on either a 
formaldehyde gel or an agarose gel. Initially a formaldehyde gel was used 
to test a sample of RNA. A 2% agarose gel was also made to test a sample 
of RNA and this RNA was loaded at different concentrations (1800µg, 
1350µg, 675µg, 225µg) on the gel. The formaldehyde gel not only required 
the use of more chemicals, but was also a lot more time consuming to make 
than a 2% agarose gel. The purpose of running the RNA samples down a 
gel was to see the two bands at 28S and 18S to assess the integrity of them, 
and this was able to be done sufficiently on an agarose gel. Therefore, only 
agarose gels were used in the following experiments.  
 
Although the 260/280 ratio values (1.9-2.10) around the recommended 
values (1.8-2.0), some contamination may be seen in the agarose gel 
(Figure 3.4) lanes A and B. These lanes were all loaded with the same 
sample, but lanes A and B were loaded with a higher concentration of RNA 
(1800ng and 1350ng) than lanes C and D (675ng and 225ng). Although 
RNA is visible in all four bands, slight genomic DNA contamination may be 
seen in the lanes loaded with more RNA. This could go on to affect any 
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further experiments done. Ideally, the RNA samples could have gone 
through a DNase treatment to remove any DNA contamination.  
 
Thus RNA purity and integrity were considered good after extraction took 
place in the exponential phase of growth. The next chapter discusses RNA 
extraction once the Thp-1 cells are stimulated with LPS, and semi-




4 Thp-1 cells induced with LPS to 
determine TNF-α expression at mRNA 
level through semi-quantitative PCR 
 
 Introduction  
LPS, an endotoxin derived from the cell wall of Gram negative bacteria, is a 
known trigger for TLR4 that leads to the production of the pro-inflammatory 
cytokine TNF-α. It is also suggested that the mitochondrial stress protein 
HSP60 triggers inflammation in the same way as LPS, by acting through 
TLR4, however some studies suggest that TLR2 may also play a role in this 
process, ultimately leading to the production of TNF-α (Kilmartin and Reen, 
2004).  
 
In this part of the project, a preliminary experiment was carried out before 
the Thp-1 cells were incubated with HSP60. Thp-1 cells (as described in 
Chapter 1.9) were incubated with 50ng/mL, 100ng/mL, and 200ng/mL of 
LPS for 6, 12 and 24 hours. RNA was extracted and cDNA was synthesised, 
followed by PCR. In order to do semi-quantitative analysis, the number of 
PCR cycles had to be run within the exponential amplification range. Once 
the optimum number of cycles were decided, semi-quantitative analysis was 














 Thp-1 cells stimulated with LPS for 6, 12, and 24 hours.  
Thp-1 cells were seeded at 3 x 105 cells (in approximately 2 mLs) into each 
well of a 6 well plate. The plate was set up as shown in the diagram below; 
each plate had a control well with Thp-1 cells and PBS, a well with Thp-1 
cells with 50ng/mL LPS, a well with Thp-1 cells with 100ng/mL LPS, and a 
well with Thp-1 cells with 200ng/mL LPS. This was incubated in a humidified 
CO2 incubator at 37°C (standard incubator conditions) for cell growth) for 6, 













 Thp-1 cells stimulated with LPS for 12 hours only 
After obtaining results from Thp-1 cells seeded with different concentrations 
of LPS for 6, 12, and 24 hours (RNA concentration and 260/280 ratio shown 
in appendix Table A1, A2 and A3 and TNF-α PCR products shown below in 
Figure 4.5), a 12 hour time frame was selected. This was based on Figure 
4.5, where bands are present for most of the 12 hour samples. Thp-1 cells 
were seeded at 3 x 105 cells (in approximately 2 mLs) into each well of a 6 
well plate. The plate was set up as shown in the diagram below; each plate 
had two control wells with Thp-1 cells and PBS, 2 wells with Thp-1 cells with 
50ng/mL LPS, and 2 wells with Thp-1 cells with 100ng/mL LPS. This was 
incubated in a humidified 5% CO2 incubator at 37°C (standard incubator 
conditions for cell growth) for 12 hours, followed by RNA extraction.  
Figure 4.1 Set up of Thp-1 cells with LPS at different 

















 RNA extraction 
The TRIzol method was carried out for RNA extraction as described in 
Chapter 2.3. 
 
 cDNA synthesis and dilution  
cDNA synthesis was done using the qScript XLT cDNA SuperMix following 
manufacturer’s directions, as described in Chapter 2.5. This was initially 
used in the PCR reactions without dilution. This resulted in no PCR product 
bands on the 2% agarose gels. Therefore, the cDNA was diluted 1:5 and 
1:10 with DEPC water, which resulted in clear PCR product bands after PCR.  
 
 PCR optimization 
 PCRs for GAPDH and TNF-α (Made up master mix)  
PCR was performed specifically for GAPDH and TNF-α. Each reaction mix 
consisted of 36.6uL DEPC water, 5uL 10x PCR buffer containing 25mM 
MgCl2 (Roche), 5uL sample cDNA, 1uL 10mM dNTP mixture (Roche), 2uL 
of each forward and reverse primers at 10mM, and 0.4uL Taq polymerase 
(Roche).  
Figure 4.2 Set up of Thp-1 cells with LPS at different 
concentrations in a 6 well plate for 12 hours. 
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The PTC-200 Peltier Thermal Cycler was used to carry out the PCR 




Table 4.1 PCR cycle conditions using the made up master mix 
Operation Temperature Time 
Initial activation 95°C 4 min 
Denaturation 95°C 1 min 
Annealing GAPDH: 63°C TNF-α: 60°C 1 min 
Elongation 72°C 1 min 




Table 4.2 Primer sequences, product sizes and annealing temperatures 
Gene Primer Sequence Product size (bp) 
Annealing 
temp °C 
GAPDH forward ACC ACA GTC CAT GCC ATC AC 
452 64 
GAPDH reverse TCC ACC ACC CTG TTG CTG TA 
TNF-α forward CAG AGG GAA GAG TTC CCC AG 
325 60 
TNF-α reverse CCT TGG TCT GGT AGG AGA CG 
 
 
 PCRs for GAPDH and TNF-α using HOT FIREPol® Blend 
Master Mix 
HOT FIREPol® Blend Master Mix was used for these PCR reactions. This 
mix was used according to manufacturer’s directions; with 15 minutes of 








Table 4.3 PCR reaction components. 
Component Volume 
HOT FirePol Blend Master Mix Ready 
to Load 4uL 
10uM forward and reverse primer 0.5ul 
DNA template 1uL 
DEPC water Up to 20uL 
 
 
Table 4.4 PCR cycle conditions using the HOT FIREPol® Blend Master Mix. 
Operation Temperature Time 
Initial Activation 95°C 15 min 
Denaturation 95°C 20 s 
Annealing GAPDH: 63°C TNF-α: 60°C 30s 
Elongation 72°C 1 min 
Final extension 72°C 10 min 
 
 Semi-quantitative PCR  
4.2.5.3.1 Cycle	number	and	time	alterations	
In order to be able to quantify the PCR products through semi-quantitative 
analysis, PCR needed to be carried out and stopped in the middle of the 
exponential growth phase (Marone et al., 2001). Once it reaches the plateau 
stage, it indicates that all the cDNA has been converted to the PCR product 
and the bands appear to be thick and bright for all of the samples, not 
allowing to determine the quantity based on band intensity, as they have 







2% agarose gels were visualised on the iBright Imaging system (Thermo 
Fisher Scientific). Using the analysis tool, the bands were auto-selected 
based on the colour difference between the background and the bands. A 
report was printed with the band intensity details (as shown in appendix, 
Table A4, A5 and A6).  
 
The method used to analyse was described in a paper by (Mitchell and 
Iadarola, 2010). First, the averages were worked out between the same 
samples in one experiment (for example, the two controls in experiment 1A, 
etc). Next the averages were worked out between all the experiments (for 
example, the average from the control averages from experiment 1A, 1B 
and 1C). From here, the fold difference was calculated by dividing the 
sample (50ng/mL and 100ng/mL of LPS) average by the control average. 
The standard deviation and standard error was calculated. 
 
 Statistical analysis 
ANOVA and the Student’s T-test was carried out on Microsoft Excel to 
determine the significance of the results. For the T-test a two tailed 
distribution was used and it was performed using 2 samples with unequal 
variants.  
 
 Results  
 RNA quality and quantity of Thp-1 cells exposed to LPS for 
12 hours 
RNA quality and quantity was measured on the Nanodrop2000 (Thermo 
Fisher). The concentrations and 260/280 ratios are shown in the three 
tables below as the experiment was repeated three times. The 
concentrations of the samples are measures based on their absorbance 
potential (Thermo Fisher Scientific, 2016). The tables shown are for the 12 
hour time point as described in methods (Chapter 4.2.2), as this was 
selected for further analysis. The RNA quantity and quality details for the 6, 
12 and 24 hour time points  as described in Chapter 4.2.1 are in the 
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appendix (Table A1, A2 and A3. As seen in the Tables 4.5, 4.6 and 4.7, the 
RNA concentrations were high enough to work with, and 260/280 ratio were 
all between 1.80-1.91. These samples were all considered sufficient and 
were used to create cDNA.  
 
Table 4.5 RNA concentrations and 260/280 ratios of Thp-1 cells induced 
with LPS for 12 hours (Experiment 1A). 
Sample RNA concentration (µg/mL) 260/280 
Control A 325.3 1.84 
Control B 234.9 1.88 
50ng/mL A 123.3 1.82 
50ng/mL B 153.1 1.80 
100ng/mL A 150.2 1.90 
100 ng/mL B 63.1 1.86 
 
 
Table 4.6 RNA concentrations and 260/280 ratios of Thp-1 cells induced 
with LPS for 12 hours (Experiment 1B). 
Sample RNA concentration (µg/mL) 260/280 
Control A 319.5 1.86 
Control B 224.1 1.82 
50ng/mL A 110.4 1.83 
50ng/mL B 112.0 1.83 
100ng/mL A 173.7 1.91 
100 ng/mL B 353.5 1.90 
 
 
Table 4.7 RNA concentrations and 260/280 ratios of Thp-1 cells induced 
with LPS for 12 hours (Experiment 1C). 
Sample RNA concentration (µg/mL) 260/280 
Control A 55.6 1.89 
Control B 92.0 1.88 
50ng/mL A 114.6 1.81 
50ng/mL B 346.0 1.81 
100ng/mL A 69.1 1.80 
100 ng/mL B 168.1 1.83 
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 RNA integrity  
RNA integrity has been described in Chapter 3.3.4. 2% Agarose gels were 
used to visualise the two RNA bands (28S and 18S) of the RNA extracted 
from Thp-1 cells following the LPS treatment for 12 hours. These can be 
seen in Figure 4.3 below. The top band is 28S and the bottom 18S. The top 
band, 28S appears thicker than the bottom band, 18S, due to its larger size. 
The bands shown appear sharp, which indicates that the RNA is still in 
folded into its tertiary structure.   
  
Figure 4.3 RNA from LPS induced cells for 12 hours run on a 2% agarose 




 Different amounts of cDNA and changes in annealing 
temperature 
When the cDNA was used without diluting it down and directly after it had 
been synthesised, no bands were seen on the gel. However, with a 1:5 and 
1:10 dilution with DEPC water, clear bands are seen on the gel (Figure 4.4). 
The samples with a 1:5 dilution of cDNA show thicker bands as excepted 
(since the cDNA was added at a higher concentration that 1:10 dilution).   
Figure 4.4 RNA from LPS induced cells for 12 hours run 
on a 2% agarose gel for 1 hour. A and B: Control with 




Figure 4.5 PCR for GAPDH using different concentrations of cDNA from 
Thp-1 cells induced with LPS for 12 hours run on a 2% agarose gel for 1 




 Different concentrations and time periods of LPS  
The 12 hour time period showed thick bands (Figure 4.5) for all three of the 
concentrations, as did the 24 hour time point. Based on these results, a 12 
hour time point was taken for the rest of the experiments, as well as the 
50ng/mL and 100ng/mL concentrations for LPS.  
 
Figure 4.6 2% agarose gel run for 1 hour showing PCR products of TNF-α 
expression From left,  A: Control with PBS, B: 50ng/mL, C: 100ng/mL, D: 
200ng/mL at 24 hours, 12 hours and 6 hours. 
 
 Semi-quantitative optimisation 
 GAPDH 
At 36 and 30 PCR cycles the GAPDH PCR product bands appeared to be 
the same thickness (figures not shown). At 25 cycles, only a very slight to 
no change can be seen in the thickness of the bands (Figure 4.6). This 
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shows that the final number of amplicons are approximately the same, 
which corresponds to the amount of cDNA that was added to the PCR mix. 
Therefore, PCR was done at 18 cycles, as seen in Figure 4.7. Here the 
bands appear very weak and differences can be seen in them.  
 
 
Figure 4.7 2% agarose gel run for 1 hour showing PCR products of GAPDH 
at 25 cycles. From left Neg: Negative control,  A and B: control with PBS, C 




Figure 4.8 2% agarose gel run for 1 hour showing PCR products of GAPDH 
at 18 cycles, with Thp-1 cells induced with LPS for 12 hours. A and B: 




At 36 cycles there are no differences in the intensity of the bands (Figure 
4.8). At 30 cycles, there are slight differences in intensity of the bands 
(Figure 4.9). When bought down to 25 cycles, no amplicons show up in the 
gel (Figure 4.10). 30 cycles was picked as an ideal cycle number to run the 






Figure 4.9 2% agarose gel run for 1 hour showing PCR products of TNF-α at 
36 cycles with Thp-1 cells incubated with LPS for 12 hours. A and B: 
Control with PBS, C and D: 50ng/mL LPS, E and F: 100 ng/mL LPS. Neg: 
Negative control. Experiment repeated 3 times. 
 
 
Figure 4.10 2% agarose gel run for 1 hour showing PCR products of TNF-α 
at 30 cycles with Thp-1 cells incubated with LPS for 12 hours. A and B: 
Control with PBS, C and D: 50ng/mL LPS, E and F: 100 ng/mL LPS. Neg: 




Figure 4.11 2% agarose gel run for 1 hour showing PCR products of TNF-α 
at 25 cycles, with Thp-1 cells induced with LPS for 12 hours. A and B: 





 Semi-quantitative Analysis 
 
TNF-α at 30 cycles and GAPDH at 25 cycles were selected as the final cycle 
numbers for the PCR reactions for semi-quantitative analysis. This is 
because at this number it was clear that the bands were not saturated, and 
differed slightly based on the expression levels of the gene. This allowed for 
the quantification of the expression of TNF-α relative to the housekeeping 
gene, GAPDH.  
 
Figure 4.12 Fold change of TNF-α expression of Thp-1 cells exposed to LPS 
for 12 hours. Black line represents control sample cells (N=3). 
 
The graph above shows that there was a very little fold change of less than 
0.5 (Figure 4.11). This is statistically insignificant (p>0.05).  
 
 Discussion  
There were two objectives of this portion of the study; to determine an 
appropriate time frame and concentration for Thp-1 cells to be incubated 
with LPS in order to generate a TNF-α response, and to optimise the 
number of cycles in PCR in order for the reactions to be stopped in the 
















Initially in the cDNA synthesis process, 1uL of cDNA that was synthesised 
from the qScript mix was added to the PCR reaction. No bands were seen 
on the 2% agarose gels when the PCR products were run down. One reason 
for this could be that an excess of cDNA from the original cDNA mix created 
may have a very high concentration. This means that when it’s added to the 
PCR reaction, it may bind all the primers, not allowing PCR to take place 
correctly (Biosynthesis, 2015). When the cDNA was diluted down 1:5 and 
1:10 (as seen in Figure 4.4), bands were seen in the gel.  
 
Initially a PCR mix was created using reagents stored in a -20°C freezer in 
the PC1 lab. After several PCR unsuccessful attempts using these reagents, 
the Hot Fire Pol mix was used. The initial reagents used were dated from 
2005, and may have become inactive during this time as they were used by 
many students and would have gone through many thawing and freezing 
cycles.  
 
As seen in Figure 4.5, the 24 hour time period was too long and no TNF-α 
induction was seen on the agarose gel. This may be because TNF-α had 
returned to its basal levels at the end of 24 hours, as seen in the research 
conducted by Schilberger et al. At 12 hours all bands were seen except for 
the 50ng/mL sample. At 6 hours all the bands were seen. In order to be able 
to incubate and extract RNA within working hours, the 12 hour time point 
was selected and concentrations of 50ng/mL and 100ng/mL were selected.  
 
The expression of TNF-α was compared with the housekeeping gene 
GAPDH, or glyceraldehyde-3-phosphate dehydrogenase. GAPDH is widely 
used for comparing gene expression data. It is a gene coding an enzyme 
that catalyses the reversible oxidative phosphorylation of glyceraldehyde-3-
phosphate in the process of glycolysis. As different tissues in the body will 
have different requirements, GAPDH expression varies considerably 




On the other hand, TNF-α expression increases when it has been induced 
due to cellular stress. Cytokines such as TNF-α, are glycoproteins secreted 
mainly by immunological cells (T-cells, macrophages, neutrophils) in 
response to disease or tissue damage (Leung and Cahill, 2010). Without a 
stressor, there is little to no expression of this gene at mRNA level (Vila-del 
Sol et al., 2008). In a study carried out by Szlosarek et al. in 2006, they 
found that TNF-α expression was detected in qPCR for normal epithelial 
cells, however was not seen when conventional PCR was done (Szlosarek 
et al., 2006). However, the control samples in these experiments (10uL of 
PBS added to Thp-1 cells only) do show an expression of TNF-α when 
conventional PCR was done. The cells may have been under stress prior to 
treating them with LPS, as there are bands visible in the control samples. 
Although the cells were kept in standard incubator conditions in a PC2 lab 
as required, any error in this may have resulted in the cells becoming slightly 
stressed, which may have triggered an inflammatory response. 
 
Another reason a TNF-α response may have been seen in the control 
samples is because of mycoplasma contamination. Mycoplasma 
contamination is one of the most common contamination concerns in cell 
cultures. Mycoplasmas are a group of prokaryotic microorganisms that do 
not have a cell wall. They are also one of the smallest self-replicating 
organisms known, and cannot be detected using a microscope. Cell cultures 
in early passage have been found to have less contamination (1-5%) 
compared to cells with higher passage numbers (15-35%). Although an 
antibiotic (penstrep) was used, mycoplasmas are resistant to most antibiotic, 
including penstrep (Drexler and Uphoff, 2002). Mycoplasma are able affect 
cell culture in a myriad of ways. They can alter the expression of hundreds 
of genes, alter protein, RNA and DNA synthesis, alter cell metabolism, 
change cell membrane composition, and alter cell morphology. 
Mycoplasma contamination can be detected reliably through PCR (Drexler, 
2002; Miller, 2003). The primers used are designed based on the highly 
conserved regions of genes that are present across all mycoplasma 




TNF-α expression was very difficult to see at 25 cycles as shown in Figure 
4.6, however GAPDH expression was seen in as little as 18 cycles (Figure 
4.7). These results show that the basal level of expression of GAPDH is 
higher than the expression of TNF-α. This may be due to the fact that 
GAPDH is always expressed as it is required for glycolysis, a process that 
allows the breakdown of glucose for ATP (Tristan et al., 2011), however 
TNF-α generally requires a cell stressor.  
 
In an ideal situation, given more time and resources, it has been suggested 
that more than one housekeeping gene should have been used for a more 
accurate quantification of TNF-α expression. Although it is inherently 
believed that the housekeeping gene’s expression remains constant in the 
samples being used, the expression may change depending on the 
circumstances or treatments Barber et al., 2005; Silver et al., 2006). In a 
study carried out by Baber et al (2005) it was found that GAPDH expression 
varied significantly between different tissue, but was very similar in the same 
tissue. As explained above, GAPDH plays a role in glycolysis. The 
expression of GAPDH would vary depending on a tissue’s needs. For 
example, a higher GAPDH expression level was seen in skeletal muscle 
and many brain regions as they require more energy (Barber et al., 2005). 
Since comparisons between TNF-α and GAPDH were made using the same 
cell line and samples, this would be considered a viable result.  
 
The number of cells used was decided on the basis of getting a good RNA 
concentration. However, this may have had an impact on the sensitivity to 
LPS. If the cell concentration was too high and more LPS was needed to 
trigger a reaction, no significant difference would have been seen.  
 
The amount of TNF-α released from Thp-1 cells induced with LPS was done 
using semi-quantitative PCR analysis, which looks at the intensity of the 
PCR product bands when they are run out on a gel, and compared to a 
housekeeping gene. Incubating Thp-1 cells with LPS for 12 hours indicated 
that there was no significant increase in TNF-α production. In a study carried 
out by Schildberger et al, a peak of TNF-α was observed at 4 hours when 
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10ng/mL of LPS was used on 106 cells, tapering off until around 24 hours 
(Schildberger et al., 2013). With concentrations at 50ng/mL and 100ng/mL 
and a time period of 12 hours, it is highly possible that the peak was reached 
not only quicker, but that over the 12 hours will also have decayed and 
would be difficult to determine from a PCR reaction. This relates to the fact 
that TNF-α mRNA is very short lived, and has a shorter stability as it has a 
very short poly(A) tail (Mijatovic et al., 2000). This is discussed further in 
Chapter 6.4. Therefore, after looking into this paper, 10ng/mL and 50ng/mL 
of LPS was used for a time period of 4 hours before extracting RNA.   
 
Another issue that was faced was optimising the PCR cycles for GAPDH in 
order to stop the amplification in the exponential stage. In Figure 4.6, the 
bands appear to almost be saturated. The number of cycles was changed 
to 18, as seen in Figure 4.7. However, the machine was unable to pick up 
the bands in this picture, and GAPDH at 25 cycles was used. This may have 
caused the results to change as the change could have been more 
accurately determined using bands that appeared less saturated. Therefore, 
it was proposed that Real Time PCR / qPCR, should be done instead, as 
seen in the following chapter.  
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5 Thp-1 cells induced with LPS to 




Based on the previous experiment, it was found that there was no significant 
TNF-α expression when semi-quantitative analysis was carried out on Thp-
1 cells exposed to LPS for 12 hours (as seen in Figure 4.5). It was noted 
that there may have been systematic error introduced through the frequent 
handling of nucleic acids. The machine was also not able to pick up the 
lower levels of PCR product bands on the agarose gels, which made it 
difficult to analyse. Therefore, qPCR was suggested as another method to 
determine relative gene expression.  
 
qPCR is a common and modern alternative to semi-quantitative PCR that 
measures DNA as it is being synthesised over time. It does this by using a 
fluorescent probe (such as SYBR green or SYTO82) that binds to double 
stranded DNA as soon as it is synthesised. The qPCR machine is able to 
measure the fluorescence and detect the amount of DNA synthesis in each 
reaction (Pfaffl, 2001). Threshold cycle, or Ct, is when the fluorescence in 
the reaction rises above background fluorescence. After the PCR is 
complete, the fluorescence of the end product is proportional to the amount 
of DNA synthesised.  
 
Using the same samples used for semi-quantitative analysis as mentioned 
in Chapter 4.31 (Table 4.5, 4.6 and 4.7), qPCR was carried out and results 
were analysed using the delta-delta Ct method as well as the Pfaffl method. 
The differences in the methods were explained and the Pfaffl method was 




 Methods  
The RNA used in this experiment was the same RNA extracted and 
described in Chapter 4. The details of its quality, quantity and integrity can 
be seen in Chapter 4.3.1 and 4.3.2. The same cDNA was used to set up the 
qPCR reactions, as explained below.  
 
 qPCR  
 Reaction set up  
qPCR was carried out on a MIC qPCR instrument (BioMolecular systems, 
Australia). Each reaction contained 2.5 MgCl2, 200uM dNTPs, 1uM forward 
and reverse primer, HotFirePol Taq polymerase, 2uM SYTO82 (Life 
Technologies), and 1uL of diluted cDNA. Each reaction had a final volume 
of 10uL. The thermocycling conditions are described in the table below. The 
PCR reactions were run for 40 cycles.  
 
Table 5.1 qPCR cycle conditions 
Gene Initial 
denaturation 
Denaturation Annealing Extension Fluorescence 
acquisition 
GAPDH 95°C  for 15 
minutes 








80°C for 10 
seconds 
TNF-α 95°C for 15 
minutes 








80°C for 10 
seconds 
 
 Analysis  
Analysis of qPCR was done using the delta-delta Ct method and the Pfaffl 
method. These two methods allow for a calculation of relative gene 
expression between samples. The main difference between the two 
methods is that the delta-delta Ct method does not account for any 
differences in the efficiency of cycles, whereas the Pfaffl method takes in 






The delta-delta Ct method presumes that the real time amplification 
efficiency values of the reference and target gene are identical and at 
their optimum value (E=2). However, in reality the efficiencies vary 
slightly and can be recorded by the qPCR systems. This method 
therefore is only applicable for making quick estimations of the 
expression ratios. The equations used are stated below, where Ct is 
threshold cycle (which is when the fluorescence picked up is above the 
background fluorescence) (Pfaffl, 2001). GOI: gene of interest, HKG: 
housekeeping gene (GAPDH),  
 
1. DCtuntreated = Ct GOIuntreated - Ct HKGuntreated 
     
2. DCttreated = Ct GOItreated - Ct HKGtreated 
 
3.    DDCt = DCttreated - DCtuntreated 
Figure 5.1 Equations used for the delta-delta Ct method to determine gene 
expression ratios between samples. Ct: Threshold cycle, GOI: gene of 
interest, HKG: housekeeping gene (GAPDH). 
5.2.1.2.2 Pfaffl	method		
The Pfaffl method is more reliable as it takes in the real time 
amplification efficiency values of the reference and target gene for each 
sample (Pfaffl, 2001). The equations used to determine relative gene 
expression are shown below.  
 
1. DCttarget = Ct GOIcontrol - Ct GOItreated 
 
2. DCtnorm = Ct NORMcontrol - Ct NORMtreated 
 
3. Fold difference = (Etarget)deltact target/(Enorm)deltact norm 
Figure 5.2 Equations used for the Pfaffl method to determine gene 
expression ratios between samples. GOI: gene of interest, NORM: 
Housekeeping gene, GAPDH, Ct: Threshold cycle. 
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 T Test for statistical analysis 
ANOVA and the Student’s T-test was carried out on Microsoft Excel to 
determine the significance of the results. For the T-test a two tailed 
distribution was used and it was performed using 2 samples with unequal 
variants. 
 
 Results  
 Delta-delta Ct Method 
The equations used to determine Dctuntreated, Dcttreated DDCt and fold 
difference are shown in Figure 5.1 The tables below (Table 5.2, 5.3, 5.4, 
and 5.5) show these results based on the threshold cycle values obtained 
from the qPCR instrument.  
 
Table 5.2 Analysis of first experiment with Thp-1 cells incubated with LPS 
at 12 hours using the Delta-delta Ct method. 
Tube Ct average Dctuntreated Dcttreated DDCt Fold difference 
TNF-α C 26.67 7.85    
TNF-α 50 25.79  6.43 -1.42 2.68 
TNF-α 100 25.88  6.41 -1.44 2.72 
GAPDH 0 18.82     
GAPDH 50 19.35     
GAPDH 100 19.47     
 
Table 5.3 Analysis of second experiment with Thp-1 cells incubated with 
LPS at 12 hours using the Delta-delta Ct method. 
Tube Ct average Dctuntreated Dcttreated DDCt Fold difference 
TNF-α C 27.61 7.50    
TNF-α 50 25.48  6.49 -1.01 2.02 
TNF-α 100 25.18  6.26 -1.24 2.36 
GAPDH 0 20.11     
GAPDH 50 18.99     





Table 5.4 Analysis of third experiment with Thp-1 cells exposed to LPS for 
12 hours using the Delta-delta Ct method. 
Tube Ct average Dctuntreated Dcttreated DDCt Fold difference 
TNF-α C 26.29 7.40    
TNF-α 50 26.46  6.22 -1.18 2.26 
TNF-α 100 25.46  6.11 -1.28 2.43 
GAPDH 0 18.89     
GAPDH 50 20.24     
GAPDH 100 19.34     
 
Table 5.5 Mean fold difference of TNF-α expression relative to HKG GAPDH 
in Thp-1 cells exposed to LPS for 12 hours using the Delta-delta Ct method. 
LPS 
(ng/mL) 
Fold d. in 
Ex. 1 
Fold d. in 
Ex 2. 
Fold d. in 
Ex 3 
Mean SD SE 
50 2.68 2.02 2.26 2.32 0.33 0.19 
100 2.72 2.36 2.43 2.50 0.19 0.11 
 
Figure 5.3 Fold change of TNF-α expression of Thp-1 cells exposed to LPS 
for 12 hours using the delta-delta method for qPCR analysis (N=3). 
 
 
Using the delta-delta method for analysis, a 2.32 fold increase is seen in the 











hours. There is only a small and insignificant (p>0.05) increase of 2.50 fold 
compared to the 2.32 fold increase when the concentration of LPS is 
increased from 50ng/mL to 100ng/mL. ANOVA and the Student’s T test 
were carried out and results were found to be insignificant (p >0.05).  
 
 Pfaffl Method 
The equations used to determine Dcttarget Dctnorm  and fold difference are 
shown in Figure 5.2. The tables below (Table 5.6, 5.7, 5.8 and 5.9) show 
these results based on the threshold cycle values obtained from the qPCR 
instrument.  
Table 5.6 Analysis of first experiment with Thp-1 cells incubated with LPS 
at 12 hours using the Pfaffl method. 
Tube Ct value Efficiency Dcttarget Dctnorm Fold difference 
TNF-α C 26.67 1.84    
TNF-α 50 25.79 1.84 0.89  2.39 
TNF-α 100 25.88 1.86 0.79  2.46 
GAPDH C 18.82 1.87    
GAPDH 50 19.35 1.87  -0.53  
GAPDH 100 19.47 1.88  -0.65  
Table 5.7 Analysis of second experiment with Thp-1 cells incubated with 
LPS at 12 hours using the Pfaffl method. 
Tube Ct value Efficiency Dcttarget Dctnorm Fold difference 
TNF-α C 27.61 1.81    
TNF-α 50 25.48 1.85 2.13  1.85 
TNF-α 100 25.18 1.85 2.44  2.10 
GAPDH C 20.11 1.88    
GAPDH 50 18.99 1.85  1.12  





Table 5.8 Analysis of third experiment with Thp-1 cells incubated with LPS 
at 12 hours using the Pfaffl method. 
Tube Ct value Efficiency Dcttarget Dctnorm Fold difference 
TNF-α C 26.29 1.84    
TNF-α 50 26.46 1.85 -0.16  2.04 
TNF-α 100 25.46 1.86 0.84  2.21 
GAPDH C 18.89 1.87    
GAPDH 50 20.24 1.84  -1.34  
GAPDH 100 19.34 1.84  -0.45  
 
Table 5.9 Mean fold difference of TNF-α expression relative to HKG GAPDH 
in Thp-1 cells exposed to LPS for 12 hours using the Pfaffl method. 
Sample Fold d. in 
Ex. 1 
Fold d. in Ex. 
2 
Fold d. in Ex. 
3 
mean sd se 
50 2.39 1.85 2.04 2.10 0.28 0.16 
100 2.46 2.10 2.21 2.26 0.19 0.11 
 
Figure 5.4 Fold change of TNF-α expression of Thp-1 cells exposed to LPS 
for 12 hours using the Pfaffl  method for qPCR analysis (N=3). 
 
The overall fold change is slightly lower when using the Pfaffl method for 
















LPS, and a 2.26 increase is seen is Thp-1 cells exposed to 100ng/mL LPS. 
As seen in the delta-delta Ct method, the fold difference between cells 
exposed to 50ng/mL and 100ng/mL LPS is insignificant, as determined by 
ANOVA and the Student’s T-test (p>0.05).  
 
 Discussion  
The objective of this portion of the study was to more accurately determine 
the expression of TNF-α when Thp-1 cells were incubated with LPS for 12 
hours. This was done through qPCR, a technique that allows the measure 
of gene expression by calculating the amount of double stranded DNA being 
synthesised over time. This was originally done using semi-quantitative 
analysis, however the results obtained did not seem accurately determined 
due to human error as well as the machine not being able to pick up lighter 
PCR product bands on the agarose gels.  
 
The results obtained from both experiments were very different. In semi 
quantitative analysis, both the 50ng/mL and 100ng/mL LPS samples had a 
fold change of ~1.1. However, using qPCR analysis methods, the fold 
change is over 2 using both methods of analysis. Although these results are 
insignificant (p>0.05), overall the qPCR change seems more accurate as it 
minimises human error by being able to record threshold cycles and 
amplification as it occurs on a machine, while in semi-quantitative, there is 
a lot more handling of the RNA and pipetting errors that could occur, which 
would affect results.  
 
The Ct average for TNF-α was 26.9, and the Ct for GAPDH was 19.34. A 
smaller Ct number indicates that there is a high level of mRNA transcripts 
of that gene, as it is rises above background fluorescence earlier, showing 
that more product has been created with fewer cycles of PCR. As expected, 
GAPDH has a lower Ct than TNF-α, as GAPDH is expressed as a result of 
the process of glycolysis, whereas TNF-α is a response to cellular stress.   
 
The results from the Delta-delta Ct method indicate a .2 higher fold change 
than the Pfaffl method. This is because as stated earlier, the Delta-delta Ct 
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method does not take in the efficiency of each sample. Instead it presumes 
the value of 2 (holding the theoretical view that each time DNA goes through 
a cycle, it doubles). In reality the cycle efficiencies vary, as seen in 
(appendix). Accounting for this in the equation makes it more accurate. 
Using the Pfaffl method it is seen that for the 50ng/mL sample a 2.32 fold 
increase was seen, and for the 100ng/mL samples a 2.50 fold increase was 
seen.  
 
Using PCR gives an indication of TNF-α expression at the mRNA level. It is 
important to note that although an increase is seen in the mRNA level, it 
may not indicate an increase in TNF-α at the protein level. A ~2 fold increase 
may not be enough to lead to protein translation, and may not lead to the 
production of TNF-α protein, thus no inflammatory response would be seen. 
In order to test for TNF-α at the protein level, techniques such as western 
blotting should be carried out.   
 
In a study carried out by Schildberger et al, a peak of TNF-α was observed 
at protein level at 4 hours when 10ng/mL of LPS was used on 106 cells, 
tapering off until around 24 hours (Schildberger et al., 2013). In this 
experiment, a very different cell number and concentration was used. With 
concentrations at 50ng/mL and 100ng/mL and a time period of 12 hours, it 
is highly possible that the peak was reached not only earlier (as the 
concentration of LPS is higher), but that over the 12 hours the expression 
of TNF-α would have slowed down or returned to basal levels. As the 2 fold 
increase seen is insignificant, after looking into this paper, a higher fold 
increase may be obtained using 10ng/mL of LPS with a time period of 4 
hours. Therefore, a 10ng/mL and 50ng/mL of LPS was used for a time 
period of 4 hours before extracting RNA, to see if the TNF-α expression 





6 Thp-1 cells induced with LPS for 4 
hours to determine TNF-α expression 
through qPCR 
 
 Introduction  
Previous research shows that in a time course of Thp-1 cells incubated with 
10ng/mL of LPS, a peak of TNF-α expression is seen at 4 hours 
(Schildberger et al., 2013). Therefore, in the previous experiment conducted, 
the time point of 12 hours may have been too long for a significant higher 
expression (over 2 fold) of TNF-α to be seen. It was also noted that semi-
quantitative results were not able to be accurately determined. Therefore, 
qPCR was used for the rest of the project. 
 
In this portion of the study, the objective was to expose Thp-1 cells to 
10ng/mL and 50ng/mL of LPS for 4 hours only. A higher fold difference was 
expected to be seen between the control samples and LPS induced 
samples, in accordance with literature (Schildberger et al., 2013).  
 
 Methods 
 Thp-1 cells incubated with LPS for 4 hours 
3 x 105 Thp-1 cells were harvested from the stock and 2mLs into 6 wells on 
a 6 well plate. Each well had 2mLs of 3 x 105 cells. The plate was set up as 
shown in the diagram. The plate was placed in the incubator under standard 
incubator conditions for 4 hours, and then RNA was extracted as described 




Figure 6.1 Set up of 6-well plate for Thp-1 cells incubated with different 
concentrations of LPS for 4 hours 
 
 RNA extraction, cDNA synthesis and qPCR 
RNA extraction, nanodrop readings, cDNA synthesis and agarose gels were 
carried out as described in Chapters 2.3, 2.4, 2.5 and 2.6 respectively. 
qPCR was carried out as described in Chapter 5.2.1.1, and analysed as 
described in Chapter 5.2.1.2.  
 
 T Test for statistical analysis 
ANOVA and a Student’s T-test was carried out using the same method 











 Results  
 RNA  
 RNA quantity and quality  
Table 6.1 RNA concentrations and 260/280 ratios of Thp-1 cells exposed to 
LPS for 4 hours. 
Sample RNA concentration 
(µg/mL) 
260/280 
Control 264.9 1.91 
10ng/mL 187.2 1.89 
50ng/mL 371.6 1.96 
 
Table 6.2 Second repeat of RNA concentrations and 260/280 ratios of Thp-1 
cells exposed to LPS for 4 hours. 
Sample RNA concentration 
(µg/mL) 
260/280 
Control 584.4 1.95 
10ng/mL 378.5 1.95 
50ng/mL 215.5 1.94 
 
Table 6.3 Third repeat of RNA concentrations and 260/280 ratios of Thp-1 
cells exposed to LPS for 4 hours. 
Sample RNA concentration 
(µg/mL) 
260/280 
Control 215.5 1.98 
10ng/mL 156.1 1.98 
50ng/mL 277.5 1.93 
 
The RNA extracted all had a concentration greater than180ng/mL, and this 
was enough to continue with cDNA synthesis. The 260/280 ratio were all 
between 1.89-1.98.  As an ideal 260/280 ratio is considered to be ~2, these 




Figure 6.2 RNA from Thp-1 cells induced with LPS for 4 hours. A: Control 
cells (with PBS), B: 10ng/mL LPS, C: 50ng/mL LPS. Experiment repeated 3 
times. 
 
RNA from all three experiments was run on a 2% agarose gel with 1xTAE 
buffer for 1 hour, as seen in Figure 6.2. The two RNA bands (28S and 18S) 
are seen clearly on the gel for each sample. Ideally, the top 28S band should 
be twice as thick as the bottom 18S band. However, as the 260/280 ratios 
were ~2, and the two bands were clear on the gel, this RNA was used for 
the rest of this experiment.  
 
  qPCR analysis 
 Delta Delta Ct method  
This is described in detail in Chapter 5.2.1.2.1 
Table 6.4 Analysis of first experiment with Thp-1 cells incubated with LPS 
at 4 hours using the Delta-delta Ct method. 
Tube Ct Average Dctuntreated Dcttreated DDCt Fold difference 
TNF-α 0 33.13 1.73    
TNF-α 10 31.18  5.75 4.02 0.061556144 
TNF-α 50 31.11  3.93 2.20 0.217686238 
GAPDH 0 31.40     
GAPDH 10 25.44     





Table 6.5 Analysis of second repeat experiment with Thp-1 cells incubated 
with LPS at 4 hours using the Delta-delta Ct method. 
Tube Ct Average Dctuntreated Dcttreated DDCt Fold difference 
TNF-α 0 30.50 2.32    
TNF-α 10 29.94  2.14 -0.17 1.127063644 
TNF-α 50 30.94  1.51 -0.81 1.748982974 
GAPDH 0 28.18     
GAPDH 10 27.80     
GAPDH 50 29.43     
 
Table 6.6 Analysis of third repeat experiment with Thp-1 cells incubated 
with LPS at 4 hours using the Delta-delta Ct method. 
 
Table 6.7 Mean fold difference of TNF-α expression relative to HKG GAPDH 
in Thp-1 cells exposed to LPS for 4 hours using the delta-delta Ct method. 
 
Tube Ct Average Dctuntreated Dcttreated DDCt Fold difference 
TNF-α 0 31.25 5.52    
TNF-α 10 30.81  7.52 2.00 0.249709364 
TNF-α 50 31.53  6.03 0.51 0.704011205 
GAPDH 0 25.73     
GAPDH 10 23.29     
GAPDH 50 25.50     
Sample Fold Av 
ex 1  
Fold av 
ex 2  
Fold av. 
ex 3  
Mean SD SE 
10ng/mL 
LPS 
0.06 1.13 0.25 0.48 0.57 0.33 
50ng/mL 
LPS 




Figure 6.3 Fold change of TNF-α expression of Thp-1 cells exposed to LPS 
for 4 hours using the delta-delta method for qPCR analysis (N=3) 
 
The delta-delta Ct method was used for analysis. When Thp-1 cells were 
exposed to 10ng/mL LPS for 4 hours, a fold increase of 1.13 was observed. 
When exposed to 50ng/mL, a 1.75 fold increase was observed. The 
difference between the samples was insignificant, as seen in a Student’s T 
test (p>0.05).  
 
 Pfaffl method  
This is explained in detail in Chapter 5.2.1.2.2 
Table 6.8 Analysis of first experiment with Thp-1 cells incubated with LPS 
at 4 hours using the Pfaffl method. 
Tube Ct Average Efficiency  Dcttarget Dctnorm Fold difference  
TNF-α 0 33.13 1.73       
TNF-α 10 31.18 1.81 1.95   0.050741989 
TNF-α 50 31.11 1.80 2.02   0.175965315 
GAPDH 0 31.40 2.00       
GAPDH 10 25.44 2.00   5.97   


















Table 6.9 Analysis of second repeat experiment with Thp-1 cells incubated 
with LPS at 4 hours using the Pfaffl method 
Tube Ct Average Efficiency Dcttarget Dctnorm Fold difference  
TNF-α 0 30.50 1.89       
TNF-α 10 29.94 1.97 0.55   1.117594808 
TNF-α 50 30.94 1.86 -0.44   1.807601073 
GAPDH 0 28.18 2.00       
GAPDH 10 27.80 2.00   0.38   
GAPDH 50 29.43 2.00   -1.25   
 
Table 6.10 Analysis of third repeat experiment with Thp-1 cells incubated 
with LPS at 4 hours using the Pfaffl method. 
Tube Ct value Efficiency Dcttarget Dctnorm Fold difference  
TNF-α 0 31.25 1.80       
TNF-α 10 30.81 1.81 0.44   0.239376721 
TNF-α 50 31.53 1.82 -0.28   0.723041936 
GAPDH 0 25.73 2.00       
GAPDH 10 23.29 2.00   2.44   
GAPDH 50 25.50 2.00   0.23   
 
Table 6.11 Mean fold difference of TNF-α expression relative to HKG 
GAPDH in Thp-1 cells exposed to LPS for 4 hours using the Pfaffl method. 
Sample Fold Av ex 1 Fold av ex 2 Fold av. ex 3 Mean SD SE 
10ng/mL 
LPS 0.05 1.12 0.24 0.47 0.57 0.33 
50ng/mL 




Figure 6.4 Fold change of TNF-α expression of Thp-1 cells exposed to LPS 
for 4 hours using the Pfaffl method for qPCR analysis (N=3) 
 
When using the Pfaffl method, only a 0.47 fold increase in TNF-α expression 
is seen when exposed to 10ng/mL of LPS, and a 0.90 fold increase seen 
when exposed to 50ng/mL of LPS. These values, though already low, are 
even lower than the ones obtained from the delta-delta analysis, and were 
not significant (p>0.05). 
 
 Discussion 
The objectives of this chapter were to determine TNF-α expression levels 
when 3 x 105 Thp-1 cells were incubated with 10ng/mL and 50ng/mL LPS 
for 4 hours. qPCR was continued to be used as it provided more accurate 
and publishable results. The concentrations (10ng/mL and 50ng/mL of LPS) 
and time point (4 hours) was selected based on a study by Schildberger et 
al. in 2013, in which the highest TNF-α expression seen in Thp-1 cells 
exposed to LPS at 10ng/mL was at 4 hours.  
 
The results from the qPCR delta-delta analysis showed a fold increase of 
for 10ng/mL of LPS, and for a 50ng/mL increase. Using the Pfaffl method, 
the fold increases were even lower; for 10ng/mL LPS a fold increase was 
observed, and for 50ng/mL LPS a fold increase was observed. Although an 
















insignificant), it is interesting to observe that the experiment carried out in 
chapter 4, with Thp-1 cells being incubated with LPS for 12 hours, has a 
higher response. This is because in the Schildberger experiment, the peak 
of TNF-α expression was seen at 4 hours using 10uL of LPS. In the 
experiment undertaken in the lab, only 3 x 105 cells were used. This was 
because initially this was a good amount of cells to use in order to extract 
RNA of a sufficient concentration. It was also difficult to obtain a large 
quantity of cells at such a concentration of 106 cells. However when 
comparing this number with 106, it should be seen that since there were less 
cells exposed to a higher amount of LPS, the overall increase would be 
expected to be higher. There may be a variety of reasons for why this was 
not seen.  
 
Firstly, the cells used had been passaged well over 30 times before they 
were exposed to LPS. Although the cells were checked under the 
microscope to see if they were healthy cells, it is possible that having 
passaged them so many times, the gene expression levels may have been 
altered or reduced over time. This could be due to clonal selection. Thp-1 
cells are an immortalized cell line and can be passaged up to 25 times 
without any changed in cell sensitivity and activity (Chanput et al., 2014). It 
would have been more reliable and accurate if the cells used were recently 
purchased and new. This could explain the experimental results in this 
chapter compared to the results seen in the Schildberger et al. 2013 paper.  
 
Given enough time and resources, it would be best to incubate Thp-1 cells 
for a variety of concentrations and time points as was done in Chapter 4.3.4, 
and then to do qPCR analysis on them to look at the different TNF-α 
expression levels. This would give a good indication of where the peak 
expression of TNF-α was with the cells being used, and it would account for 
any differences that would have occurred because factors such as passage 
number.   
 
LPS in the lab was stored in plastic Eppendorf tubes. At a concentration of 
lower than lower than 0.1mg/mL, it has been recommended that LPS be 
stored in glass tubes/containers as it is able to bind to the plastic. Also, 
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repeated freeze thaw cycles are not recommended. The LPS used was from 
a made up stock in the -20 freezer of the E3.11 lab at the University of 
Waikato. This LPS had been used my students before being used for this 
experiment and would have undergone several freeze thaw cycles. Being 
kept in a plastic tube may have reduced the concentration of LPS slightly, 
as it is able to bind to the plastic as well as some kinds of glass. This is 
especially prominent when LPS is stored at concentrations lower than 
0.1mg/mL (Merck, 2018).  
 
It would have made the experiment more reliable if a duplicate of each 
sample was done in all of the three experiments, as it was done in Chapter 
4. However due to a time shortage and availability of resources, only 1 
sample at each concentration was used for each of the three experiments. 
If a larger sample size was taken, this would help to reduce the large 
standard errors in the experiments.  
 
It is widely agreed upon that low quality RNA can compromise gene 
expression results (Fleige et al., 2006). It becomes important to isolate a 
high quality of RNA from many samples. Looking back to Tables 6.1, 6.2 
and 6.3, the  260/280 ratio of all samples are between 1.89-1.98. In Figure 
6.2, the RNA shows clear 28S and 18S bands.  However, it is possible that 
some genomic DNA is present in the samples, as seen by the light smears 
below the 18S bands. Given more time and resources, the RNA extracted 
could have been put through a DNAse treatment.  
 
Not only is mRNA very unstable (especially long pieces of mRNA), it is 
possible that through frequent handling RNAses may be introduced (Fleige 
et al., 2006).  It has been reported that TNF-α mRNA has a very short half-
life. Although TNF-α is produced at its maximum levels seen when it is 
exposed to LPS, it’s mRNA remains short lived. The poly A tail added to 
mRNA helps to keep the mRNA stable. It has been shown that TNF-α 
mRNA has very short homogenous poly(A) tails compared to GAPDH 
mRNA, which has a long pol(A) tail from ~70 to ~220 nucleotides. (Mijatovic 




Although the results were insignificant, a greater fold change was seen 
when LPS was incubated with  LPS for 12 hours. Therefore it would be 
suitable for the next experiment to be incubating Thp-1 cells with  HSP60 
for 12 hours. However due to time constraints, a 4 hour HSP60 experiment 
has been set up and conducted before the analysis of the  results in this 
chapter. This will be presented in the following chapter. 
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7 Thp-1 cells induced with HSP60 for 4 
hours to determine TNF-α expression 
through qPCR 
 
7.1 Introduction  
HSP60 is a protein known to be released upon cell stress, such as increased 
temperatures and high glucose environments (Chapter 1.6). It is the only 
HSP that shows a direct link to atherosclerosis through experimental and 
clinical trials (Wick et al., 2014).  The movement of this protein to the cell 
surface has been recognised as a stress response and correlates strongly 
with the development of cardiovascular disease (Grundtman et al., 2011). 
 
HSP60 has been suggested to activate TLR4, similar to the way LPS does 
and may trigger a signalling cascade that ultimately leads to the release of 
pro-inflammatory cytokines such as TNF-α. More recent studies show that 
HSP60 may also be able to activate TLR2 (Kilmartin and Reen, 2004). In 
this portion of the study, Thp-1 cells were incubated with different 
concentrations of HSP60 (500ng/mL and 1500ng/mL based on HSP60 
levels found in diabetic patients by Yuan et al., 2011) for 4 hours to 
determine an increase in TNF-α expression at mRNA level could be seen.   
 
 Methods 
 Endotoxin removal from human HSP60 grown in E.Coli 
The human HSP60 used in this project was a recombinant protein 
expressed in E.coli. Endotoxin was removed from HSP60 using the Pierce 
High Capacity Endotoxin Removal kit using the manufacturer’s directions. 
First the spin column was bought to room temperature. The column’s bottom 
closure was twisted off and the cap loosened. It was placed in a collection 
tube and spun at 500 x g for 1 minute in a centrifuge to remove the storage 
solution, which was discarded. A bottom plug was added to the column and 
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the cap was removed. To regenerate, 2mL 0.2 NaOH was added and the 
cap was replaced. The column was inverted several times to suspend the 
resin in the solution and this was incubated overnight at room temperature. 
The next day the cap was loosened and bottom plug was removed. The 
column was placed in a collection tube and centrifuged at 500 x g for 1 
minute, and the solution in the collection tube was discarded. After removing 
the cap and inserting a bottom plug, 2mL of 2M NaCl was added. The cap 
was tightened and the column was inverted several times to resuspend the 
resin in solution. The cap was loosened and bottom plug removed, and the 
column was placed in a collection tube and spun at 500 x g for 1 minute.  
The solution in the collection tube was discarded. The cap was removed 
and plug inserted, and 2 mL of endotoxin-free ultra-pure water was added. 
The cap was tightened and the column inverted several times, resuspending 
the resin. After loosening the cap and removing the plug, the column was 
put inside a collection tube and spun for 500 x g for 1 minute. The solution 
in the collection tube was discarded. The cap was removed and plug 
inserted, and 2 mL of endotoxin free buffer was added. The column was 
inverted several times to resuspend the resin. The plug was removed and 
cap loosened, and the column was placed in a collection tube and spun at 
500 x g for 1 minute. The solution was discarded. This was repeated twice 
more with the endotoxin buffer. Then the plug was inserted and HSP60 was 
added to the column. After tightening the cap, the column was left with 
gentle end over end mixing at room temperature for four hours. Then the 
cap was loosened, plug removed, and column placed in a collection tube. 
This was spun at 500 x g for 1 minute to collect endotoxin-free HSP60.  
 
 Thp-1 cells Incubated with HSP60  
Thp-1 cells were seeded at 3 x 105 cells (in approximately 2mLs) into 5 
wells of a 6-well plate. The plate was set up as shown in the diagram below. 
In the first well, 10uL of PBS was added as a control. The next well had 
500ng/mL of HSP60 added, followed by 1500ng/mL HSP60, 500ng/mL of 
untreated (endotoxin not removed) HSP60, and lastly 1500ng/mL untreated 
HSP60.  This was incubated in a humidified CO2 incubator at 37°C 
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(standard incubator conditions for cell growth) for 4 hours, followed by RNA 
extraction.  
 
Figure 7.1 Set up of 6 well plate with Thp-1 cells and different 
concentrations of HSP60 
 
 RNA extraction, cDNA synthesis and qPCR 
RNA extraction, nanodrop readings, cDNA synthesis and agarose gels were 
carried out as described in Chapters 2.3, 2.4, 2.5 and 2.6 respectively. 
qPCR was carried out and analysed as described in Chapter 5.2.1. 
 
 Statistical analysis 
ANOVA and the Student’s T-test was carried out on Microsoft Excel to 
determine the significance of the results. For the T-test a two tailed 
distribution was used and it was performed using 2 samples with unequal 
variants.  
 
 Results  
 RNA  
 Quantity and quality  
The tables (Table 7.1, 7.2, 7.3) present the concentrations and 260/280 
ratios of the RNA extracted from Thp-1 cells incubated with HSP60 for 4 
hours. The concentrations were all suitable for cDNA synthesis. The 
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260/280 ratios, range from 1.75-1.98, with 1 sample 1.68. Although this 
value is considered low compared to threshold values, however,  these 
samples were used in this experiment, as there were 2 repeats of this 
experiment (as shown in Table 7.1 and 7.2).  
Table 7.1 RNA concentrations and 260/280 ratios of Thp-1 cells exposed to 
HSP60 for 4 hours. 
Sample RNA concentration (µg/mL) 260/280 
Control 256.8 1.93 
500ng/mL endotoxin 
removed HSP60 174.2 1.81 
1500ng/mL endotoxin 
removed HSP60 108.2 1.87 
500ng/mL untreated 
HSP60 237.2 1.90 
1500ng/mL untreated 
HSP60 239.4 1.88 
 
Table 7.2 Repeat of RNA concentrations and 260/280 ratios of Thp-1 cells 
exposed to HSP60 for 4 hours. 
Sample RNA concentration (µg/mL) 260/280 
Control 199.6 1.82 
500ng/mL endotoxin 
removed HSP60 271.9 1.87 
1500ng/mL endotoxin 
removed HSP60 298.0 1.88 
500ng/mL untreated 
HSP60 223.8 1.89 
1500ng/mL untreated 










Table 7.3 Repeat of RNA concentrations and 260/280 ratios of Thp-1 cells 
exposed to HSP60 for 4 hours. 
Sample RNA concentration (µg/mL) 260/280 
Control 168.8 1.84 
500ng/mL endotoxin 
removed HSP60 301.6 1.85 
1500ng/mL endotoxin 
removed HSP60 219.3 1.75 
500ng/mL untreated 
HSP60 78.7 1.76 
1500ng/mL untreated 
HSP60 98.2 1.68 
 RNA Integrity  
 
Figure 7.2 RNA from Thp-1 cells induced with HSP60 for 4 hours. A: Control 
with PBS, B: .5µg/mL HSP60, C: 1.5µg/mL HSP60, D: .5µg/mL HSP60 (with 
endotoxin), E: 1.5µg/mL HSP60 (with endotoxin). 
 
The RNA was run on a 2% agarose gel for 1 hour at 70V. Figure 7.2 shows 
RNA extracted from Thp-1 cells incubated with HSP60 for 4 hours. The 
figure shows 2 clear bands, the top band being 28S RNA subunit, and the 
bottom one 18S RNA. As expected, the 28S band appears thicker than the 
bottom 18S band due to its larger size. 
 
 qPCR analysis 
 Delta-delta Ct Method  
The three tables (Table 7.4, 7.5, 7.6) show the average Ct of the 
experimental duplicates. Following this, using the delta-delta Ct equations 
as shown in Figure 5.1  the Dctuntreated, DCttreated, DDCt and fold difference 
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was worked out. Table 7.7 shows the average Ct of the samples between 
all 3 experiments, with the fold difference worked out as mean. 
 
Table 7.4 Analysis of first experiment with Thp-1 cells incubated with 
HSP60 for 4 hours using the delta-delta Ct method. 
Tube Ct average Dctuntreated Dcttreated DDCt Fold difference 
TNF C 25.43 6.80    
TNF 500 30.40  4.40 -2.40 5.27 
TNF 1500 40.00  10.37 3.57 0.08 
TNF U500 27.80  7.26 0.46 0.73 
TNF U1500 30.66  11.17 4.37 0.05 
GAPDH C 18.63     
GAPDH 500 26.00     
GAPDH 1500 29.63     
GAPDH U500 20.54     
GAPDH U1500 19.49     
 
 
Table 7.5 Analysis of second repeat experiment with Thp-1 cells incubated 
with HSP60 for 4 hours using the delta-delta Ct method. 
Tube 
Ct 
average Dctuntreated Dcttreated DDCt 
Fold 
difference 
TNF C 28.11 4.65    
TNF 500 32.02  8.72 4.07 0.06 
TNF 1500 40.00  14.87 10.22 0.00 
TNF U500 28.22  8.19 3.54 0.09 
TNF U1500 29.91  7.67 3.02 0.12 
GAPDH C 23.46     
GAPDH 500 23.30     
GAPDH 1500 25.13     
GAPDH U500 20.03     
GAPDH 







Table 7.6 Analysis of first experiment with Thp-1 cells incubated with 
HSP60 for 4 hours using the delta-delta Ct method. 
Tube Ct average Dctuntreated Dcttreated DDCt Fold difference 
TNF C 27.78 7.11    
TNF 500 31.43  4.84 -2.27 4.83 
TNF 1500 31.42  5.92 -1.19 2.28 
TNF U500 27.96  6.26 -0.85 1.80 
TNF U1500 32.39  9.61 2.50 0.18 
GAPDH C 20.67     
GAPDH 500 26.59     
GAPDH 1500 25.49     
GAPDH U500 21.70     
GAPDH U1500 22.77     
 
Table 7.7 Mean fold difference of TNF-α expression relative to HKG GAPDH 
in Thp-1 cells exposed to HSP60 for 4 hours using the delta-delta Ct 
method. 
Sample Fold Av ex 1 Fold av ex 2 Fold av. ex 3 Mean SD SE 
500.00 5.27 0.06 4.83 3.39 2.89 1.67 
1500.00 0.08 0.00 2.28 0.79 1.29 0.75 
U500 0.73 0.09 1.80 0.87 0.87 0.50 





Figure 7.3 Fold change of TNF-α expression of Thp-1 cells exposed to 
HSP60  for 4 hours using the delta-delta method for qPCR analysis (N=3). 
 
The graph indicates that the highest fold change of 3.39 was seen in the 
Thp-1 cells incubated with 500ng/mL of HSP60 for 4 hours. The rest of the 
samples had a fold change of less than 1, with the untreated 500ng/mL 
HSP60 samples having a 0.87 fold change, the 1500ng/mL HSP60 samples 
with a .79 fold change and untreated 1500ng/mL HSP60 with a 0.12 fold 
change. These results were statistically insignificant. 
 
 Pfaffl method 
The three tables (Table 7.8, 7.9, 7.10) show the average Ct of the samples. 
Dcttarget, Dctnorm, and fold difference was worked out using the Pfaffl 
equations shown in Figure 5.2. Table 7.11 shows the average Ct of the 





















Table 7.8 Analysis of first experiment with Thp-1 cells incubated with 
HSP60 for 4 hours using the Pfaffl method. 
Tube Ct value Efficiency Dcttarget Dctnorm Fold difference 
TNF C 25.43 1.92    
TNF 500 30.40 1.92 -4.97  4.25 
TNF 1500 40.00 1.92 -14.57  0.09 
TNF U500 27.80 1.89 -2.36  0.75 
TNF U1500 30.66 1.87 -5.23  0.07 
GAPDH C 18.63 1.90    
GAPDH 500 26.00 1.89  -7.37  
GAPDH 1500 29.63 1.91  -11.00  
GAPDH U500 20.54 1.90  -1.91  
GAPDH U1500 19.49 1.90  -0.86  
 
Table 7.9 Analysis of second repeat experiment with Thp-1 cells incubated 





y Dcttarget Dctnorm 
Fold 
difference 
TNF C 28.11 1.91    
TNF 500 32.02 1.84 -3.92  0.08 
TNF 1500 40.00 1.84 -11.89  0.00 
TNF U500 28.22 1.90 -0.12  0.10 
TNF U1500 29.91 1.94 -1.81  0.14 
GAPDH C 23.46 1.90    
GAPDH 500 23.30 1.90  0.15  
GAPDH 
1500 25.13 1.94  -1.68  
GAPDH 
U500 20.03 1.89  3.43  
GAPDH 








Table 7.10 Analysis of third repeat experiment with Thp-1 cells incubated 
with HSP60 for 4 hours using the Pfaffl method. 
Tube Ct value Efficiency Dcttarget Dctnorm Fold difference 
TNF C 27.78 1.92    
TNF 500 31.43 1.91 -3.65  4.64 
TNF 1500 31.42 1.90 -3.64  2.00 
TNF U500 27.96 1.82 -0.18  1.74 
TNF U1500 32.39 1.88 -4.61  0.22 
GAPDH C 20.67 1.88    
GAPDH 500 26.59 1.93  -5.92  
GAPDH 1500 25.49 1.87  -4.82  
GAPDH U500 21.70 1.90  -1.03  
GAPDH U1500 22.77 1.94  -2.11  
 
Table 7.11 Mean fold difference of TNF-α expression relative to HKG 




Sample Fold Av ex 1 Fold av ex 2 Fold av. ex 3 Mean SD SE 
C500 4.25 0.08 4.64 2.99 2.53 1.46 
C1500 0.09 0.00 2.00 0.70 1.13 0.65 
U500 0.75 0.10 1.74 0.86 0.82 0.48 




Figure 7.4 Fold change of TNF-α expression of Thp-1 cells exposed to 
HSP60 for 4 hours using the Pfaffl method for qPCR analysis (N=3). 
 
The Pfaffl method gave slightly lower results than the delta delta Ct method. 
Like the delta delta Ct method, the highest fold difference (2.99) was seen 
in the Thp-1 cells incubated with 500ng/mL of HSP60 for 4 hours. This was 
followed by the untreated 5000ng/mL HSP60 (0.86), 15oong/mL HSP60 
(0.70) and lastly, untreated 1500ng/mL HSP60 (0.14). These results were 
statistically insignificant.  
 
 Discussion 
The objective of this chapter was to see how much TNF-α was being 
expressed at mRNA level when incubated with different concentrations of 
HSP60. The concentrations of HSP60 used were 500ng/mL and 1500ng/mL. 
These were chosen based on the amount of HSP60 found in the serum of 
type 2 diabetic patients (28 -1043ng/mL) (Yuan et al., 2011). 
 
The HSP60 was expressed in the Gram negative bacteria called 
Escherichia coli. LPS is found in the outer wall of all Gram negative bacteria. 
Therefore, any recombinant protein expressed in E. coli will have LPS 
(endotoxin) contamination. LPS, as previously explained is a ligand for 


















of inflammatory cytokines. Therefore, in order to determine if the HSP60 
was triggering the TNF-α response, the LPS needed to be removed. This 
was done using a high capacity endotoxin removal column as explain in 
Chapter 7.2.1. In the results it was expected that both the samples of HSP60 
that did not go through the spin column (untreated or U) would show a 
heightened expression of TNF-α. However, both the untreated samples 
show a lower expression than the treated samples. One reason for this may 
be that the spin column method did not work efficiently. This could have 
been tested through the Lumulus Amebocyte Lysate (LAL) test. This test 
uses the blood of a horseshoe crab, Limulus Polyphemus, which clots up 
when it comes into contact with Gram negative bacteria, revealing the 
presence of LPS (Novitsky, 1994). There are kits that use this method and 
detect the presence of LPS by colour change or through gelation (GenScript, 
2018).  
 
Interestingly, it was seen that the highest fold increase in the results was 
with 500ng/mL of HSP60 at 3-fold. At 1500ng/mL of HSP60, only a ~ 1 fold 
change was seen. This may be because at a high concentration of 
1500ng/mL the TNF-α response occurs much quicker in the cells. This 
means that the TNF-α mRNA would be transcribed faster, and since the 
TNF-α mRNA is short lived, as discussed in Chapter 6.4, the mRNA may 
have already been degraded at the end of 4 hours. Ideally a time course 
could be carried out, where HSP60 at 500ng/mL were incubated with Thp-
1 cells for 2, 4, 6, 8, 10 hours etc. This would give a good indication of where 
the mRNA of TNF-α is being expressed the highest. TNF-α should also be 
measured at the protein level, as it is at the protein level that it would have 
an inflammatory response on the target cells. This could be done through 
ELISA.  
 
In a study carried out by Ueki et al. in 2002, 10µg/mL of HSP60 was 
incubated with Thp-1 cells for 12 hours, and revealed an increase of TNF-α 
production through ELISA (~110pg/mL) as compared to control (5pg/mL). 
Only human HSP60 was used, as bacterial HSP60 (or GroEL/GroES) did 
not induce TNF-α in Thp-1 cells (Ueki et al., 2002). Looking at literature, it 
seems that a more appropriate time frame for HSP60 induction of Thp-1 
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cells would have been 12 hours. However the concentration used in this 
experiment (500ng/mL and 1500ng/mL) was essential, as it represented the 
amount of HSP60 found in the serum of diabetic patients (30-1000ng/mL) 
(Yuan et al., 2011). It was thought that a TNF-α expression would be seen 
a lot earlier since the concentration used was very high compared to the 
10ng/mL of LPS in 2 x 106 cells/mL used in Ueki et al study. Also, it has 
been indicated through research that LPS and HSP60 used very similar 
methods of triggering a TNF-α response, so 4 hours was picked as an 
appropriate time frame. Unfortunately, due to time constraints, the 4 hour 
LPS experiment and 4 hour HSP60 experiment were set up around the 
same time, not giving enough time in between to analyse results. If the 
results had been analysed before setting up the HSP60 experiment, a 12 
hour time frame may have been selected, as the highest TNF-α response 
with LPS is seen with 100ng/mL of LPS for 12 hours (Figure 5.4).  
 
Initial research indicated that HSP60 activated monocytes and 
macrophages through a complex consisting TLR4, but studies indicate that 
TLR2 is also able to respond to HSP60 (Kilmartin and Reen, 2004). 
However, more research tends to be based around the TLR4 activation of 
HSP60. It was discovered by Xu et al. in 2001 that aortic root lesions of high 
fat diet-fed mice expressed TLR4 mRNA expression higher than control 
mice, and that TLR4 mRNA expression could be upregulated when human 
monocyte derived macrophages were exposed to LDL particles (as seen in 
atherosclerotic plaques) (Xu et al., 2001). It has been generally indicated 
through literature that HSP60 may use TLR4 to trigger an inflammatory 
response that contributes to atherogenesis. To prove this, the next step in 
this research would to generate a TNF-α response curve using different time 
points to determine the highest point of TNF-α expression (as mentioned 
earlier). Then the Thp-1 cells could be incubated with TAK-242, an 
antagonist TLR4. This would be followed by exposing the Thp-1 cells with 
HSP60 for the ideal time frame determined by the TNF-α expression curve. 
If it is found that TNF-α has been markedly reduced, it would indicate that 
HSP60 was using TLR4 to mediate an inflammatory response. It is 
interesting to note that exposure to TNF-α can also lead to a higher 
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expression of HSP60 (Ferm et al., 1992). This creates a cycle that may lead 





8 Concluding remarks and Future 
Directions 
 
The question of how diabetes mellitus is linked to cardiovascular diseases 
has been asked for decades, yet a molecular mechanism linking the two 
diseases is yet to be found. This project investigated the expression of a 
pro-inflammatory cytokine, TNF-α  when Thp-1 cells were exposed to LPS 
(a known trigger to TNF-α ) and HSP60 (a pro-inflammatory mediator 
elevated in diabetic patients). Thp-1 cells were used to mimic monocytes, 
the most abundant cell type found in atherosclerotic plaques.   
 
Thp-1 cells were incubated with 50ng/mL, 100ng/mL and 200ng/mL of LPS 
for 6, 12, and 24 hour periods. Based on the results shown in Chapter 4.3.4, 
a time period of 12 hours was initially selected for the rest of the experiments. 
The concentrations of LPS used were 50ng/mL and 100ng/mL. RNA was 
extracted using the TRIzol method, and cDNA was synthesised. Initially 
semi-quantitative analysis was done on these samples, however after 
human error and the lengthy process of determining cycle numbers, qPCR 
was selected as a more appropriate method. qPCR was carried out for TNF-
α  and GAPDH, and after analysis a 2 fold increase was seen. However 
after doing a Student’s T test, these results were considered to be 
statistically not-significant. Thp-1 cells were then incubated with 10ng/mL 
and 50ng/mL of LPS for 4 hours (based of research values), however the 
results obtained during this study was once again shown to be not 
significant.  
 
Despite the positive control not working (given the documented evidence in 
the literature which has shown LPS to be a potent inducer of TNF-α 
expression), the effect of exposing Thp-1 cells to clinically relevant levels of 
HSP60 was investigated. Thp-1 cells were incubated with 500ng/mL and 
1500ng/mL of human HSP60 for 4 hours. After qPCR analysis, a ~3 fold 
increase was seen in the samples of Thp-1 cells incubated with 500ng/mL 
of HSP60. The results were not statistically significant. However, since a 
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small increase was seen, the experiment could have been repeated with 
more samples, which would reduce the errors made in the experiments and 
may have shown an increase in the expression of TNF-α.  
 
In a recent paper published by Martinus and Goldsbury in 2017, it was 
clearly demonstrated that when Thp-1 cells were grown in the presence of 
glucose 25mM glucose, HSP60 levels increased by 3 fold compared to Thp-
1 cells grown in 5mM glucose (Martinus & Goldsbury, 2017). It was also 
demonstrated that when a human endothelial cell line was incubated with 
25mM glucose conditioned media (containing HSP60), an increase of TNF-
α  at the protein level was observed. However when the HSP60 was 
immune-depleted from the media, a significantly lower TNF-α  expression 
was seen (Martinus and Goldsbury, 2017).   
 
Although the exact mechanism has not been demonstrated, literature does 
point towards HSP60 playing a role in the inflammatory condition in diabetes, 
which leads to the development of an inflamed vascular state, stimulating 
atherogenesis. Given that HSP60 (released from monocytes grown under 
hyperglycaemic conditions) was capable of triggering the release of TNF-α  
(from endothelial cells) may be an important factor causing vascular 
inflammation, the next step would be to investigate ways to repress the 
expression of HSP60. This could be done at mRNA level by microRNA 
approaches (Shan et al., 2010). MicroRNAs are small single stranded RNAs 
that are primarily involved in negatively regulating gene expression. They 
can act as silencers by selective base pairing and reduce target gene 
expression by inhibiting translation initiation or degrading the mRNA  (Betel 
et al., 2008). By stopping the mRNA of HSP60, it would be ensured that the 
protein was not synthesised and it would not be able to activate TLRs  
 
Another approach could also be to target the receptor complex and signal 
transduction pathways responsible for the HSP60 mediated induction of 
TNF-α. Current research is not able to show exactly what TLR HSP60 uses 
to trigger an inflammatory response in target cells. When significant 
increase in TNF-α expression was seen by incubating Thp-1 cells with 
human HSP60, the next step in this project could be to use an antagonist 
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for TLR4, the receptor that HSP60 has been hypothesised to use the most. 
One such antagonist is TAK-242. TAK-242 is a cyclohexane derivative. This 
novel small molecule compound binds to TLR4 and is able to stop signal 
transduction, therefore stopping the production of cytokines. TLR4 is well 
documented to be involved in the production of pro-inflammatory cytokines. 
The activation or suppression of TLR4 has been seen to have an effect on 
the development and progression of many inflammatory diseases. TAK-242 
is able to disrupt the interaction between TLR4 with its adaptor molecules 
TIRAP and TRAM by binding directly via Cys747 in the TIR domain of TLR4. 
When TAK-242 was used on the human embryonic kidney cell line HEK293, 
it bound specifically to TLR4, limiting the expression of inflammatory 
cytokines such as TNF-α. This small-molecule-specific inhibitor is a good 
target for treating inflammatory diseases (Matsunaga et al., 2011).  
 
An interesting study also showed that the addition of purified recombinant 
human HSP10 was able to lower TNF-α  expression in RAW cells when 
triggered by LPS. It was suggested that HSP10 reacted with HSP60, and 
inhibited it from activating TLRs (Johnson et al., 2005). HSP60 also acts as 
a chaperonin for folding proteins, and there are a few HSP60 inhibitors that 
reduce its folding ability, such as mizoribine (a purine nucleotide analog 
isolated from fungi) (Itoh et al., 1999). Another inhibitor is a small molecule 
inhibitor, a pyrazolo-pyrimidine derivative EC3016. This inhibitor interacts 
with the ATP binding pocket of HSP60 and inhibits it’s ATPase activity, and 
overall reduce its ability to fold proteins (Chapman et al., 2009). However it 
is not certain that these inhibitors would have an effect on the other 





Figure 8.1 HSP60 release from monocytes under high glucose conditions 
leading to non-resolved endothelial inflammation. 
 
As shown in the diagram below, an elevated level of HSP60 in the 
bloodstream can interact with TLRs of the endothelium, and trigger the 
release of pro-inflammatory cytokines. Although this research limits itself to 
the expression of TNF-α, other pro-inflammatory cytokines such as 
interleukins can also be tested for. Interestingly, as monocytes themselves 
have TLRs, an autocrine effect may also be seen, in which HSP60 released 
from the monocyte cells may interact with the TLRs on the cells themselves. 
This would enhance TNF-α production and lead to non-resolved vascular 
inflammation.  
 
Although this project was only able to show insignificant increases of TNF-
a expression at the mRNA level when incubated with LPS and HSP60, it is 
important to note that the incubation of Thp-1 cells with LPS and HSP60 
has been well documented in literature. The next step in this area of 
research would be to focus on what receptor HSP60 is using to trigger a 
pro-inflammatory response. Using microRNA and receptor antagonists 
could be a good start to elucidating the pathway of HSP60 and 
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Table A1. Concentration and 260/280 ratio of RNA extracted from Thp-
1 cells exposed to LPS for 6 hours. 
Sample (LPS ng/mL) Concentration 260/280 
C 226.7 1.87 
50 117.3 1.90 
100 62.7 1.55 
200 281.2 1.93 
 
 
Table A2. Concentration and 260/280 ratio of RNA extracted from Thp-
1 cells exposed to LPS for 12 hours. 
Sample (LPS ng/mL) Concentration 260/280 
C 181.9 1.89 
50 384.4 2.00 
100 93.0 1.95 
200 291.0 2.02 
 
Table A3. Concentration and 260/280 ratio of RNA extracted from Thp-
1 cells exposed to LPS for 24 hours. 
Sample (LPS ng/mL) Concentration 260/280 
C 141.5 1.77 
50 127.2 2.01 
100 220.2 1.98 










PCR band density data (from iBright 
Imaging system software) 
 
Table A4. Cell density data for Thp-1 cells incubated with LPS for 12 
hours (Ex. 1). 
Sample Volume Area Density Median Local Cor. Vol. Local Cor. Density Rf 
GAPDH 
C1 1.29E+07 585 21,983 21,461.00 4.57E+06 7,811 0.156 
TNF-α 
C1 8.15E+06 468 17,407 17,555.00 1.92E+06 4,100 0.629 
GAPDH 
C2 1.90E+07 585 32,420 31,685.00 9.35E+06 15,986 0.156 
TNF-α 
C2 1.05E+07 468 22,529 22,649.00 3.68E+06 7,869 0.629 
GAPDH 
50 1 1.45E+07 468 30,922 31,385.00 6.46E+06 13,805 0.155 
TNF-α 
50 1 1.40E+07 532 26,330 25,588.00 5.34E+06 10,042 0.630 
GAPDH 
50 2 1.50E+07 468 31,934 32,205.00 6.63E+06 14,167 0.155 
TNF-α 
50 2 1.50E+07 546 27,511 26,917.00 5.66E+06 10,363 0.630 
GAPDH 
100 1 1.84E+07 546 33,666 33,032.00 8.45E+06 15,466 0.1542 
TNF-α 
100 1 1.20E+07 456 26,238 25,588.00 4.45E+06 9,757 0.6303 
GAPDH 
100 2 1.56E+07 570 27,336 25,654.00 6.07E+06 10,641 0.1517 
TNF-α 














Table A5. Cell density data for Thp-1 cells incubated with LPS for 12 
hours (Ex. 2). 




C1 1.21E+07 585 20,629 18,852.00 2.69E+06 4,591 0.150 
TNF-α 
C1 8.25E+06 456 18,097 18,199.00 1.07E+06 2,355 0.629 
GAPDH 
C2 1.84E+07 507 36,333 35,597.00 9.48E+06 18,695 0.151 
TNF-α 
C2 1.02E+07 492 20,665 20,870.00 2.24E+06 4,559 0.629 
GAPDH 
50 1 1.69E+07 507 33,402 32,978.00 7.99E+06 15,757 0.151 
TNF-α 50 
1 1.31E+07 546 23,995 23,203.00 4.17E+06 7,634 0.630 
GAPDH 
50 2 1.62E+07 585 27,691 25,095.00 6.44E+06 11,003 0.150 
TNF-α 50 
2 1.35E+07 574 23,574 22,538.00 4.18E+06 7,285 0.630 
GAPDH 
100 1 1.75E+07 507 34,590 33,288.00 8.58E+06 16,915 0.151 
TNF-α 
100 1 1.44E+07 532 27,073 26,660.00 5.58E+06 10,491 0.630 
GAPDH 
100 2 1.63E+07 507 32,163 31,655.00 7.55E+06 14,891 0.151 
TNF-α 


























Table A6. Cell density data for Thp-1 cells incubated with LPS for 12 
hours Ex. 3. 
 
 




C 1 1.84E+07 585 31,421 29,843.00 8.37E+06 14,305 0.150 
TNF-α 
C1 9.91E+06 468 21,180 21,155.00 2.48E+06 5,291 0.629 
GAPDH 
C 2 1.76E+07 570 30,943 27,468.00 7.62E+06 13,359 0.150 
TNF-α 
C2 1.13E+07 468 24,069 23,919.00 3.84E+06 8,214 0.629 
GAPDH 
50 1 1.28E+07 468 27,438 26,681.00 5.17E+06 11,046 0.150 
TNF-α 
50 1 1.00E+07 546 18,374 17,995.00 1.70E+06 3,109 0.628 
GAPDH 
50 2 1.54E+07 570 27,072 24,480.00 6.17E+06 10,826 0.150 
TNF-α 
50 2 1.26E+07 546 23,059 22,772.00 4.08E+06 7,472 0.628 
GAPDH 
100 1 1.66E+07 507 32,753 31,333.00 8.24E+06 16,253 0.151 
TNF-α 
100 1 1.18E+07 546 21,641 20,445.00 3.73E+06 6,832 0.628 
GAPDH 
100 2 1.14E+07 456 25,058 24,053.00 4.25E+06 9,308 0.150 
TNF-α 














This data was collected when qPCRs were carried out for each experiment 
using the MIC qPCR instrument (BioMolecular systems, Australia).  
 
Table A7. qPCR data for Thp-1 cells stimulated with LPS for 12 hours 
for GAPDH (Ex. 1). 
Well Sample Cq Efficiency R² 
1 AC 19.38932874 0.856199114 0.99827 
2 AC 19.28082443 0.869697435 0.99861 
3 AC1 18.21937992 0.893314714 0.99885 
4 AC1 18.38813664 0.863695635 0.99808 
5 A50 19.09060523 0.882732495 0.99864 
6 A50 19.29035527 0.865977506 0.99861 
7 A50.1 19.46365385 0.864866407 0.9984 
8 A50.1 19.56651863 0.860698356 0.99842 
9 A100 18.96113961 0.905359825 0.99819 
10 A100 19.05844951 0.891051964 0.99864 
11 A100.1 19.6089853 0.851736061 0.99832 





Table A8. qPCR data for Thp-1 cells stimulated with LPS for 12 hours 
for GAPDH (Ex. 2). 
Well Sample Cq Efficiency R² 
13 BC 21.13708234 0.860925907 0.99855 
14 BC 21.03970005 0.880621358 0.99868 
15 BC1 19.21756066 0.862309655 0.99847 
16 BC1 19.04794929 0.897936314 0.99872 
17 B50 18.87079887 0.839166636 0.99885 
18 B50 18.84447968 0.832599856 0.99873 
19 B50.1 19.11773941 0.869910476 0.9985 
20 B50.1 19.12239565 0.87546126 0.99857 
21 B100 18.85097339 0.843803127 0.9988 
22 B100 18.93859087 0.904759156 0.99807 
23 B100.1 18.74705058 0.857370838 0.99861 
24 B100.1 19.10689858 0.872063054 0.99856 
 
TABLE A9. qPCR data for Thp-1 cells stimulated with LPS for 12 
hours for GAPDH (Ex 3). 
Well Sample Cq Efficiency R² 
25 CC 19.0957157 0.886946098 0.99864 
26 CC 19.17977337 0.860372003 0.99832 
27 CC1 18.6011912 0.864653335 0.99836 
28 CC1 18.70167474 0.855278736 0.99837 
29 C50 20.61954675 0.845811581 0.99835 
30 C50 20.58677819 0.841449597 0.99825 
31 C50.1 19.95175002 0.825996094 0.99876 
32 C50.1 19.78202007 0.842117442 0.9988 
33 C100 18.77844804 0.858031477 0.99857 
34 C100 18.82558295 0.845946809 0.99883 
35 C100.1 19.71245932 0.851111365 0.99876 




Table A10 qPCR data for Thp-1 cells stimulated with LPS for 12 hours 
for GAPDH negative controls. 
Well Sample Cq Efficiency R² 
37 NEG -1 -1  
38 NEG -1 -1  
 
 
Table A11. qPCR data for Thp-1 cells stimulated with LPS for 12 
hours for TNF-α (Ex. 1). 
Well Sample Cq Efficiency R² 
1 AC 27.23560763 0.849697306 0.99875 
2 AC 27.02209039 0.840220628 0.99884 
3 AC1 26.27259717 0.827118186 0.99847 
4 AC1 26.16518709 0.835267828 0.99851 
5 A50 25.41561441 0.842942708 0.99875 
6 A50 25.27480351 0.849753163 0.99869 
7 A50.1 26.15415285 0.839140718 0.99859 
8 A50.1 26.30358754 0.815716595 0.9983 
9 A100 25.33532382 0.848252957 0.99875 
10 A100 25.72119567 0.863494153 0.99883 
11 A100.1 26.80771342 0.85984002 0.99897 





Table A12. qPCR data for Thp-1 cells stimulated with LPS for 12 
hours for TNF-α (Ex. 2). 
Well Sample Cq Efficiency R² 
13 BC 28.13878152 0.77522857 0.99759 
14 BC 27.86799259 0.799287955 0.99833 
15 BC1 27.22537607 0.827179469 0.99834 
16 BC1 27.22075255 0.829957475 0.99849 
17 B50 25.19575221 0.849399805 0.99865 
18 B50 25.60514595 0.824119817 0.99901 
19 B50.1 25.43486942 0.846040635 0.99881 
20 B50.1 25.67736071 0.860708733 0.99876 
21 B100 25.25658555 0.841298214 0.99754 
22 B100 25.28690221 0.84154523 0.99842 
23 B100.1 25.00716776 0.855942948 0.99882 
24 B100.1 25.15167363 0.843299029 0.99869 
 
Table A13. qPCR data for Thp-1 cells stimulated with LPS for 12 
hours for TNF-α (Ex. 3). 
Well Sample Cq Efficiency R² 
25 CC 26.56900842 0.820132286 0.99894 
26 CC 26.64092804 0.87104907 0.99891 
27 CC1 25.94338175 0.845113542 0.99873 
28 CC1 26.01040514 0.843318185 0.99873 
29 C50 27.05323984 0.854337253 0.99896 
30 C50 27.12461142 0.847855141 0.99885 
31 C50.1 25.84379139 0.857573 0.99885 
32 C50.1 25.80178085 0.853952039 0.99891 
33 C100 25.08844893 0.850581664 0.99882 
34 C100 25.22112663 0.846462271 0.99859 
35 C100.1 26.01527169 0.857909355 0.99892 




Table A14. qPCR data for Thp-1 cells stimulated with LPS for 12 
hours for TNF-α negative controls. 
Well Sample Cq Efficiency R² 
37 NEG -1 -1  
38 NEG -1 -1  
 
 
Table A15. qPCR data for Thp-1 cells stimulated with LPS for 4 hours 
for GAPDH (Ex. 1). 
Well Sample Cq Efficiency R² 
1 E1 con 31.66842411 0.989747288 0.99927 
2 con 31.14100642 1.025981643 0.99918 
3 10 25.51918274 1.159156427 0.99837 
4 10 25.35373566 1.042758007 0.99921 
5 50 27.31661331 1.038015067 0.99911 
6 50 27.0505123 1.067813985 0.9988 
 
 
Table A16. qPCR data for Thp-1 cells stimulated with LPS for 4 hours 
for GAPDH (Ex. 2). 
Well Sample Cq Efficiency R² 
7 e2 con 28.10514166 1.074944764 0.99877 
8 con 28.25332881 1.038306735 0.99904 
9 10 27.77982907 1.095399625 0.99824 
10 10 27.82262828 1.085218651 0.99857 
11 50 29.55989162 1.014939725 0.99939 





Table A17. qPCR data for Thp-1 cells stimulated with LPS for 4 hours 
for GAPDH (Ex. 3). 
Well Sample Cq Efficiency R² 
13 3e con 26.09897467 1.062308492 0.99889 
14 con 25.35857867 1.044015775 0.99917 
15 10 23.49089712 1.18587482 0.99823 
16 10 23.09305019 1.127635148 0.99796 
17 50 25.54667439 1.187977927 0.9982 
18 50 25.45766932 1.157945941 0.99842 
 
Table A18. qPCR data for Thp-1 cells stimulated with LPS for 4 hours 
for GAPDH negative control. 
Well Sample Cq Efficiency R² 
19 neg -1 -1  
 
Table A19. qPCR data for Thp-1 cells stimulated with LPS for 4 hours 
for TNF-α (Ex. 1). 
Well Sample Cq Efficiency R² 
20 E1 con 
TNF-α 
35.06862591 0.614640146 0.9871 
21 con TNF-α 31.19164465 0.837029968 0.99733 
22 10 TNF-α 31.04683334 0.79969027 0.99506 
23 10 TNF-α 31.32083176 0.822327728 0.99664 
24 50 TNF-α 31.22181432 0.764645728 0.99554 




Table A20. qPCR data for Thp-1 cells stimulated with LPS for 4 hours 
for TNF-α (Ex. 2). 
Well Sample Cq Efficiency R² 
26 e2 TNF-α 30.98145978 0.842370063 0.99777 
27 con TNF-α 30.0092559 0.930471866 0.99897 
28 10 TNF-α 29.38431458 1.024069115 0.99906 
29 10 TNF-α 30.50525001 0.915103561 0.99844 
30 50 TNF-α 30.25220243 0.91864061 0.99878 
31 50 TNF-α 31.62480309 0.794592856 0.99748 
 
Table A21. qPCR data for Thp-1 cells stimulated with LPS for 4 hours 
for TNF-α (Ex. 3). 
Well Sample Cq Efficiency R² 
32 3e con TNF-α 31.12001615 0.794720785 0.99665 
33 con TNF-α 31.37621845 0.807608009 0.99531 
34 10 TNF-α 31.14693632 0.799694499 0.99663 
35 10 TNF-α 30.47904859 0.83009539 0.99661 
36 50 TNF-α 31.51073571 0.825293308 0.997 
37 50 TNF-α 31.54494867 0.810910142 0.99676 
 
Table A22. qPCR data for Thp-1 cells stimulated with LPS for 4 hours 
for TNF-α negative control. 
Well Sample Cq Efficiency R² 






Table A23. qPCR data for Thp-1 cells stimulated with HSP60 for 4 
hours for GAPDH (Ex. 1). 
Well Sample Cq Efficiency R² 
1 B1 Control 18.69087635 0.893804824 0.99994 
2 B1 Control 18.57205422 0.913582121 0.99992 
3 B1 500ng 26.28813319 0.895436693 0.99997 
4 B1 500ng 25.70616598 0.878339556 0.99996 
5 B1 1500ng 29.62530421 0.910393458 0.99999 
6 B1 1500ng 29.6395002 0.90506872 0.99995 
7 B1 U 500ng 20.54322155 0.890644261 0.99999 
8 B1 U 500ng 20.53334545 0.90332767 0.99999 
9 B1 U 1500ng 19.43411722 0.903879442 0.99999 
10 B1 U 1500ng 19.54103313 0.892420492 0.99999 
 
Table A24. qPCR data for Thp-1 cells stimulated with HSP60 for 4 
hours for GAPDH (Ex. 2). 
Well Sample Cq Efficiency R² 
11 B2 Control 23.42913901 0.89746006 0.99999 
12 B2 Control 23.48130515 0.907602063 0.99996 
13 B2 500ng 23.29998009 0.912458895 0.99993 
14 B2 500ng 23.30395455 0.89722406 0.99992 
15 B2 1500ng 25.22026601 0.906334536 0.99997 
16 B2 1500ng 25.04800754 0.969011559 0.99994 
17 B2 U 500ng 20.24403607 0.893014071 0.99997 
18 B2 U 500ng 19.81529475 0.89480579 0.99996 
19 B2 U 1500ng 22.21683444 0.876711377 0.99999 





Table A25 qPCR data for Thp-1 cells stimulated with HSP60 for 4 
hours for GAPDH (Ex. 3). 
Well Sample Cq Efficiency R² 
21 B3 Control 20.84149876 0.86744179 0.99999 
22 B3 Control 20.49658408 0.882827569 0.99998 
23 B3 500ng 26.57491811 0.934667683 0.9999 
24 B3 500ng 26.59913546 0.929367088 0.99992 
25 B3 1500ng 25.66749081 0.873938128 0.99998 
26 B3 1500ng 25.32048788 0.86665606 0.99892 
27 B3 U 500ng 21.56846103 0.901213725 0.99998 
28 B3 U 500ng 21.82937885 0.900035751 0.99996 
29 B3 U 1500ng 22.68531981 0.939741559 0.99993 
30 B3 U 1500ng 22.86421808 0.93318024 0.99993 
 
Table A26. qPCR data for Thp-1 cells stimulated with HSP60 for 4 
hours for GAPDH negative controls. 
Well Sample Cq Efficiency R² 
31 neg -1 -1  






Table A27. qPCR data for Thp-1 cells stimulated with HSP60 for 4 
hours for TNF-α (Ex. 1). 
Well Sample Cq Efficiency R² 
1 B1 Control 25.23825063 0.934950474 0.99996 
2 B1 Control 25.62831079 0.904541313 0.99997 
3 B1 500ng 30.17121317 0.899820033 0.99991 
4 B1 500ng 30.63056519 0.932111241 0.99988 
5 B1 1500ng    
6 B1 1500ng    
7 B1 U 500ng 28.0070355 0.883778086 1 
8 B1 U 500ng 27.5855153 0.906156841 0.99998 
9 B1 U 1500ng 30.29722605 0.886174054 0.99998 
10 B1 U 1500ng 31.0251914 0.848738681 0.99988 
 
Table A28. qPCR data for Thp-1 cells stimulated with HSP60 for 4 
hours for TNF-α (Ex. 2). 
Well Sample Cq Efficiency R² 
11 B2 Control 28.1253283 0.911861792 0.99991 
12 B2 Control 28.08500316 0.916738616 0.99994 
13 B2 500ng 30.97542075 0.88275932 0.99991 
14 B2 500ng 33.06648151 0.787388971 0.9988 
15 B2 1500ng 8.791426482 0.039146744 0.9302 
16 B2 1500ng    
17 B2 U 500ng 28.24608311 0.882056009 1 
18 B2 U 500ng 28.19534939 0.921334052 0.99999 
19 B2 U 1500ng 30.25479583 0.959399391 0.99996 





Table A29. qPCR data for Thp-1 cells stimulated with HSP60 for 4 
hours for TNF-α (Ex. 3). 
Well Sample Cq Efficiency R² 
21 B3 Control 27.67190262 0.916666826 0.99992 
22 B3 Control 27.89064927 0.925072331 0.99992 
23 B3 500ng 31.01995223 0.915356066 0.99992 
24 B3 500ng 31.83425541 0.907715262 0.99962 
25 B3 1500ng 31.18259736 0.894062627 0.9999 
26 B3 1500ng 31.65002215 0.900140132 0.99984 
27 B3 U 500ng 27.87551662 0.773970155 0.99941 
28 B3 U 500ng 28.04288115 0.869938694 0.99989 
29 B3 U 1500ng 32.23579271 0.863371171 0.99946 
30 B3 U 1500ng 32.54315002 0.902493634 0.99911 
 
Table A30. qPCR data for Thp-1 cells stimulated with HSP60 for 4 
hours for TNF-α negative controls. 
Well Sample Cq Efficiency R² 
31 neg -1 -1  
32 neg -1 -1  
 
 
